Method of chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infection

ABSTRACT

Disclosed is a new drug application of a  Pithecellobium Clypearia  Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR)  Acinetobacter Baumannii  (MDRAB), an MDR  Pseudomonas Aeruginosa  (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing  Escherichia Coli  (ECO) and an ESBL-producing  Klebsiella Pneumonia  (KPN).

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation application of PCT applicationNo. PCT/CN2017/071671 filed on Jan. 19, 2017, which claims the benefitof Chinese patent application Nos. 201610308716.7, 201610308717.1,201610308207.4 and 201610308718.6, each filed on May 10, 2016. Thecontents of all of the above are hereby incorporated by reference.

TECHNICAL FIELD

The present disclosure relates to a new drug application of aPithecellobium Clypearia Benth Extract (EA), and particularly, to amethod of the EA used for treating multiple diseases caused by drugresistant bacteria infection.

BACKGROUND

The twenty-first century is an age of Multi-Drug Resistant (MDR)bacteria. After 60 years of clinical use of an antibiotic, more and morehospital infections and infections with the MDR bacteria have become amajor challenge to clinical antibacterial treatment at present. Since afirst case of clinical Methicillin-Resistant Staphylococcus Aureus(MRSA) infected patient was reported by Jerons in 1961, the MRSAinfections have gradually spread all over the world till now. In 2011,China Bacterial Resistance Surveillance in clinic showed that, indistribution of main drug resistant bacteria, escherichia coli andklebsiella pneumonia produced Extended-Spectrum Beta-Lactamase (ESBL)strains respectively were 50.7% and 38.5%, and the transition andcurrent status of the drug resistance thereof are highly concerned. Inaddition, according to an annual report 2010 from a Drug ResistanceSurveillance Cooperating Group of Ministry of Health, pathogenicbacteria separated by acinetobacter baumannii and pseudomonas aeruginosain a hospital ICU ranked the top, and the drug resistance rates of theacinetobacter baumannii to imipenem (IMP) and meropenem respectivelywere up to 60.4% and 61.4%. To sum up, in various MRSA and ESBL producedbacteria, the clinical occupied rates of the MDR Acinetobacter Baumannii(MDRAB) and Pseudomonas Aeruginosa (MDRPA) have been growing every year.Under the pressure that the drug resistance rates are risingcontinuously, the antibiotic treatment is facing an enormous challenge.In order to prevent further deterioration of a bacterial drug resistantphenomenon, experts and scholars are sparing no effort to discover a newmethod for inhibiting bacterial growth and treating a bacteria-induceddisease. A research has been reported and proved that traditionalChinese herbal medicines such as Coptis chinensis, Scutellariabaicalensis and Forsythia suspensa have a certain inhibition effect todifferent drug resistant bacteria. The key to further research theChinese herbal medicine to inhibit the growth of the drug resistantbacteria is to discover a new Chinese herbal medicine with a strongerbactericidal capacity and a wider drug resistant inhibitory spectrum.

With Pithecellobium bigemimum (L.) Benth as a scientific name, thePithecellobium clypearia Benth is dry young branches and leaves ofmimosa pithecellobium plant that is the Pithecellobium clypearia Benth.It is cold, tastes bitter and has the effects of clearing away heat andtoxic materials, astringing dampness and healing sore. It is a uniquesouthern medicinal material for treating multiple heat toxin symptoms.

Currently, there has disclosed in a literature that the Pithecellobiumclypearia Benth and an extract thereof have an antiviral effect, butlacks a research in an effect of the Pithecellobium clypearia Benth andthe extract thereof in aspect of anti-drug resistant bacteria.

SUMMARY

In order to overcome the above defects, the present disclosure disclosesan application of an EA in preparing a drug resistant bacteria resistantdrug and in an aspect of a sensibilization effect by using with asimilar antibiotic thereof, specifically:

1. a method of the EA used for treating disease caused by an MDRABresistant infection, in which the EA is used with an antibiotic IMP orTetracycline (TE) or Polymycin B (POLB) or Ceftazidime (CAZ) orLevofloxacin (LVX) and all show an obvious sensibilization effect;

2. a method of the EA used for treating disease caused by an MDRPAresistant infection, in which the EA is used with an antibiotic LVX orIMP or Amikacin (AMK) or CAZ or Cefoperazone (CFP) and all show anobvious sensibilization effect;

3. a method of the EA used for treating disease caused by anESBL-producing Escherichia Coli (ECO) resistant infection, in which theEA is used with an antibiotic AMK or Compound Sulfamethoxazole (SXT) andall show an obvious sensibilization effect;

4. a method of the EA used for treating disease caused by anESBL-producing Klebsiella Pneumonia (KPN) resistant infection, in whichthe EA shows an obvious inhibitory effect to the ESBL-producing KPN.

The EA preferably is a Pithecellobium clypearia Benth water extract or aPithecellobium clypearia Benth ethanol extract.

A method for preparing the EA is as follows: extracting Pithecellobiumclypearia Benth coarse powder with water or an ethanol aqueous solutionhaving a concentration of 10%-95% by a volume ratio, and then extractingan obtained extracting solution with ethyl acetate, in which theobtained extract is a final product. The ethanol aqueous solutionpreferably is an ethanol aqueous solution having the concentration of60% by the volume ratio.

In the present disclosure, the drug includes a human drug or an animaldrug, or a soil treatment drug or preparation.

The present disclosure achieves the following beneficial effects.

The present disclosure first discloses the antibacterial effect of theEA to the MDRAB, the MDRPA, the ESBL-producing ECO and theESBL-producing KPN and the sensibilization effect by using with theantibiotics thereof.

A test proves that the EA by using with the IMP or the TE or the POLB orthe CAZ or the LVX has a synergistic effect to the MDRA resistance, andcompared with the single use, the usage of the antibiotic is reduced by50%-87%.

The EA by using with the LVX or the IMP or the AMK or the CAZ or the CFPhas a synergistic effect to the MDRPA resistance, and compared with thesingle use, the usage of the antibiotic is reduced by 50%-99.2%.

The EA by using with the AMK or the SXT has a synergistic effect to theESBL-producing ECO, and compared with the single use, the usage of theantibiotic is reduced by 75%-99.3%.

The EA in the present disclosure can be taken as a natural antibacterialdrug for the above drug resistant bacteria or a sensitizer similar tothe antibiotic, and is applied to treatment of a disease caused by theabove bacteria. The present disclosure provides a new way and areplacement drug to solve the drug resistant problem of the antibiotics,and is applied to the human drug, other animal drugs and soilremediation of corresponding infectious bacteria. It is a natural plantextract and has no side effect, and the extracting method is simple andenvironment-friendly.

DETAILED DESCRIPTION OF THE EMBODIMENTS

The EA to resist the drug resistant bacteria and the pharmacologicalactions of the sensibilization effect to similar antibiotics will befurther described with the reference to the following implementationsolutions.

Preparation of the EA: the Pithecellobium clypearia Benth is provided byGuangzhou Huacheng Pharmaceutical Factory. An appropriate amount ofPithecellobium clypearia Benth medicinal materials are taken and arecrushed into coarse powder; the coarse powder is reflowed for two timeswith water or with a 10%-95% ethanol aqueous solution, each time for 2h, and is filtered; filtrates are merged and are condensed to obtain anextractum (namely, the Pithecellobium clypearia Benth water or ethanolextract); after being taken and suspended in the water, the extractum isextracted with ethyl acetate for three times, and ethyl acetateextracting solutions are merged and are condensed to obtain an ethylacetate extract. The extract obtained by reflowing with a 10% ethanolaqueous solution is referred to as a Pithecellobium clypearia Benth 10%ethanol extract, and the extract obtained by reflowing with otherconcentrations of ethanol aqueous solutions are by that analogy.

Strains: test strains in the present disclosure all are provided by theClinical Microbiology Lab of Department of Lab Medicine at FirstAffiliated Hospital of Sun Yat-Sen University and the drug resistance istested and confirmed by the same.

Mycoplasma Hominis (MH) broth culture medium: 2.1 g of MH broth drypowder (British OXOID LTD.) is taken and a volume is fixed to 100 ml;the pH is adjusted to 7.0 with NAOH; and the culture medium issterilized at a high pressure and is placed into a refrigerator at 4° C.for later use.

Determination methods of a Minimal Inhibitory Concentration (MIC) and aMinimum Bactericidal Concentration (MBC) of a test product: the MIC andthe MBC of the Pithecellobium clypearia Benth water or ethanol extractto the MDRAB are determined by a microdilution broth method. And it isoperated by referring to the microdilution broth method recommended byNational Committee for Clinical Laboratory Standards (NCCLS).

Test methods of the sensibilization effects of the test product tosimilar antibiotics: it is operated by referring to a checkerboard assayrecommended by NCCLS.

I. Inhibitory and bactericidal tests of MDRA resistance of the EA andtest of the sensibilization effect by respectively using with the IMP orthe TE or the POLB or the CAZ or the LVX

Embodiment 1

1. Test Method

1) MIC Determination

The EA, the IMP, the TE, the POLB, the CAZ and the LVX are respectivelydiluted in the MH broth culture medium by a series of ratios, with eachpore for 50 μl; the inoculant bacteria are adjusted to 1.0*10⁶ CFU/mland 50 μl of a bacteria solution is added to each pore; the culture isat 35° C. and for 24 h; and the concentration, at which no precipitateoccurs, of a minimum antibacterial drug is the MIC.

2) MBC Determination

A spread plate count method is adopted. 50 μl of bacterial suspension isabsorbed from a pore for sterile growth in item 1) to a blood plate, isuniformly coated and is cultured for 24 h at 35° C. Bacterial coloniesare counted, and the concentration, at which the initial number ofexperimental viable bacteria is reduced by 99.9% or more, of the minimumantibacterial drug is the MBC.

By determining the MIC and the MBC of the drug and making statistics ofthe data to obtain MIC₅₀, MIC₉₀, MBC₅₀ and MBC₉₀, the effect of the MDRAresistance of the drug is evaluated.

3) Checkerboard Assay

The checkerboard assay is performed in a 96-pore sterile culture plate.The EA, the IMP, the TE, the POLB and the CAZ are respectively dilutedinto a series of concentrations in a doubling manner in the MH brothculture medium, and two drugs are combined respectively at ¼MIC to 4MIC; 25 μl of A drug and 25 μl of B drug are respectively added to eachpore, the concentration of the bacterial suspension is adjusted to1.0*10⁶ CFU/ml, 50 μl of the bacteria solution is inoculated to eachpore and is cultured for 24 h at 35° C.; and then, the MIC to the MDRABafter the A drug is used with the B drug is observed.

Calculation of a Fractional Inhibitory Concentration (FIC): FIC=S20bcombined-use MIC/S20b single-use MIC+antibiotic combined-useMIC/antibiotic single-use MIC. By calculating the FIC, the combinedantibacterial interaction between the EA and the antibiotic isevaluated, with synergistic effect for FIC≤0.5, additive effect for0.5<FIC≤1, indifferent effect for 1<FIC≤2 and antagonistic effect forFIC>2. According to a sterile growth pore, the optimum concentrationratio between the EA and the antibiotic is founded out. At last, theeffect of the EA to strengthen the efficacy of the antibiotic isevaluated.

The test products in the embodiment include: the Pithecellobiumclypearia Benth water extract, the Pithecellobium clypearia Benth 10%ethanol extract, the Pithecellobium clypearia Benth 60% ethanol extractand the Pithecellobium clypearia Benth 95% ethanol extract.

The MDRABs are numbered as A1-A20.

2. Test Results

2.1 In-vitro inhibitory test results of the Pithecellobium clypeariaBenth water extract and the five antibiotics (the IMP, the TE, the POLB,the CAZ and LVX) to the MDRABs are shown in table A1.

In-vitro bactericidal test results of the Pithecellobium clypearia Benthwater extract to the MDRABs are shown in table A2.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth water extract and the fiveantibiotics to the MDRABs is shown in table A3.

The statistic analysis on MBC₅₀ and MBC₉₀ of the Pithecellobiumclypearia Benth water extract to the MDRABs is shown in table A4.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth water extract and the five antibiotics and distributionstatistical results of the FIC values are shown in table A5 and tableA6.

The sensibilization effects of the Pithecellobium clypearia Benth waterextract to the five antibiotics and the MIC₅₀ and MIC₉₀ after combineduse are shown in tables A7-A12.

TABLE A1 In-vitro inhibitory test results of the Pithecellobiumclypearia Benth water extract and the five antibiotics to the MDRABs MIC(μg/ml) Strain No. EA IMP TE LVX CAZ POLB A1 600 1 2 0.5 128 8 A2 600 32256 16 512 2 A3 600 32 256 4 512 2 A4 600 8 8 0.5 256 2 A5 600 32 32 464 4 A6 600 32 256 8 >512 8 A7 600 32 512 8 >512 4 A8 600 32 256 4 512 8A9 600 32 256 4 512 1 A10 600 16 128 32 512 32 A11 600 32 256 4 512 16A12 600 32 512 32 512 2 A13 600 32 512 32 256 2 A14 600 32 256 16 5120.5 A15 1200 32 >512 32 256 2 A16 600 32 512 8 512 4 A17 600 16 512 16256 64 A18 600 32 512 8 512 4 A19 600 32 512 16 256 4 A20 600 32 256 16512 2 ATCC27853 300 1 8 1 4 1

TABLE A2 In-vitro bactericidal test results of the Pithecellobiumclypearia Benth water extract to the MDRABs Strain No. MBC (μg/ml) A11200 A2 1200 A3 1200 A4 1200 A5 1200 A6 1200 A7 1200 A8 1200 A9 1200 A101200 A11 1200 A12 1200 A13 1200 A14 1200 A15 2400 A16 1200 A17 1200 A181200 A19 1200 A20 1200

TABLE A3 Statistical results on in-vitro inhibitory MIC₅₀ and MIC₉₀ ofthe Pithecellobium clypearia Benth water extract and the antibiotics tothe MDRABs MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 600-1200 600 600 IMP1-32 32 32 TE  2-512 256 512 POLB 0.5-64  4 16 CAZ 64-512 512 512 LVX0.5-32  8 32

TABLE A4 Bactericidal MIC₅₀ and MIC₉₀ of the Pithecellobium clypeariaBenth water extract to the MDRABs MBC (μg/ml) Drug Range MBC₅₀ MBC₉₀ EA1200-2400 1200 1200

TABLE A5 FIC values of the combined drug sensitive test of thePithecellobium clypearia Benth water extract and the five antibioticsStrain FIC No. EA + IMP EA + TE EA + POLB EA + CAZ EA + LVX A1 1 1 1.50.75 0.625 A2 1 1 1 1 1.5 A3 1 0.75 1.25 0.75 0.375 A4 0.625 0.75 0.50.625 0.375 A5 1.5 0.375 0.375 1 0.5 A6 1 0.5 0.5 1 1 A7 1 1 0.75 1 1 A81 1 1.007813 1 1.25 A9 1.5 0.75 1.0625 0.375 0.265625 A10 1 1.5 0.5 10.75 A11 1.25 0.75 0.5 1 1 A12 1 0.75 1.03125 0.5 0.5625 A13 1.5 0.5 1.51 0.75 A14 0.375 0.375 0.625 0.375 1 A15 0.375 0.3125 0.53125 1 0.501953A16 0.5 0.625 0.515625 1.125 0.5 A17 0.375 1.25 1.03125 0.625 1 A180.375 0.75 1.5 1 0.375 A19 0.5 0.375 1 1 1 A20 0.5 0.5 1 0.375 0.5

TABLE A6 Distribution statistics of the FIC values of the combined drugsensitive test of the Pithecellobium clypearia Benth water extract andthe five antibiotics EA + EA + EA + EA + EA + FIC_Range IMP TE POLB CAZLVX FIC ≤ 0.5 35% 35% 25% 20% 35% 0.5 < FIC ≤ 1 45% 55% 35% 75% 55% 1 <FIC ≤ 2 20% 10% 40%  5% 10% FIC > 2 — — — — —

TABLE A7 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the IMP and MIC after combined use EA EA IMP IMP Strainsingle-use combined-use single-use combined-use No. MIC (μg/ml) MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 1 0.5 A2 600 300 32 16 A3 600300 32 16 A4 600 300 8 1 A5 600 600 32 16 A6 600 300 32 16 A7 600 300 3216 A8 600 300 32 16 A9 600 600 32 16 A10 600 300 16 8 A11 600 600 32 8A12 600 300 32 16 A13 600 600 32 16 A14 600 150 32 4 A15 1200 300 32 4A16 600 150 32 8 A17 600 150 16 2 A18 600 75 32 8 A19 600 150 32 8 A20600 150 32 8

TABLE A8 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the TE and MIC after combined use EA EA TE TE Strainsingle-use combined-use single-use combined-use No. MIC (μg/ml) MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 2 1 A2 600 300 256 128 A3 600300 256 64 A4 600 300 8 2 A5 600 150 32 4 A6 600 150 256 64 A7 600 300512 256 A8 600 300 256 128 A9 600 300 256 64 A10 600 600 128 64 A11 600300 256 64 A12 600 150 512 256 A13 600 150 512 128 A14 600 150 256 32A15 1200 300 1024 64 A16 600 300 512 64 A17 600 600 512 128 A18 600 300512 128 A19 600 150 512 64 A20 600 150 256 64

TABLE A9 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the POLB and MIC after combined use EA EA POLB POLBStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 600 8 4 A2 600 300 2 1 A3 600600 2 0.5 A4 600 150 2 0.5 A5 600 150 4 0.5 A6 600 150 8 2 A7 600 300 41 A8 600 600 8 0.0625 A9 600 600 1 0.0625 A10 600 150 32 8 A11 600 15016 4 A12 600 600 2 0.0625 A13 600 600 2 1 A14 600 300 0.5 0.0625 A151200 600 2 0.0625 A16 600 300 4 0.0625 A17 600 600 64 2 A18 600 600 4 2A19 600 300 4 2 A20 600 300 2 1

TABLE A10 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the CAZ and MIC after combined use EA EA CAZ CAZ Strainsingle-use combined-use single-use combined-use No. MIC (μg/ml) MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 150 128 64 A2 600 300 512 256 A3600 150 512 256 A4 600 300 256 32 A5 600 300 64 32 A6 600 300 1024 512A7 600 300 1024 512 A8 600 300 512 256 A9 600 150 512 64 A10 600 300 512256 A11 600 300 512 256 A12 600 150 512 128 A13 600 300 256 128 A14 600150 512 64 A15 1200 600 256 128 A16 600 600 512 64 A17 600 300 256 32A18 600 300 512 256 A19 600 300 256 128 A20 600 150 512 64

TABLE A11 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the LVX and MIC after combined use EA EA LVX LVX Strainsingle-use combined-use single-use combined-use No. MIC (μg/ml) MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 0.5 0.0625 A2 600 300 16 16A3 600 150 16 2 A4 600 150 0.5 0.0625 A5 600 150 4 1 A6 600 300 8 4 A7600 300 8 4 A8 600 150 4 4 A9 600 150 4 0.0625 A10 600 300 32 8 A11 600300 4 2 A12 600 300 32 2 A13 600 300 32 8 A14 600 300 16 8 A15 1200 60032 0.0625 A16 600 150 8 2 A17 600 300 16 8 A18 600 150 8 1 A19 600 30016 8 A20 600 150 16 4

TABLE A12 MIC₅₀ and MIC₉₀ of the five antibiotics after combined useAntibiotic (μg/ml) Combined drug MIC₅₀ after combined use MIC₉₀ aftercombined use EA + IMP 8 16 EA + TE 64 128 EA + POLB 1 4 EA + CAZ 128 256EA + LVX 2 8

With the single use of the Pithecellobium clypearia Benth water extractto the MDRABs, the MIC₅₀ is 600 μg/ml, the MIC₉₀ is 600 μg/ml, the MBC₅₀is 1200 μg/ml, and the MBC₉₀ is 1200 μg/ml.

It is indicated by FIC≤1 with the combined use of the Pithecellobiumclypearia Benth water extract and the IMP that the two drugs have thesynergistic effect or partial synergistic effect, wherein 35% withFIC≤0.5 have the synergistic effect. For the 20 MDRABs, when theconcentration of the Pithecellobium clypearia Benth water extract issmaller than or equal to the single-use MIC, the MIC₅₀ of the IMP isreduced from single-use 32 μg/ml to 8 μg/ml and is reduced by 75%; andthe MIC₉₀ is reduced from 32 μg/ml to 16 μg/ml and is reduced by 50%.

It is indicated by FIC≤1 with the combined use of the Pithecellobiumclypearia Benth water extract and the TE to the 20 MDRABs that the twodrugs have the synergistic effect or partial synergistic effect, wherein35% with FIC≤0.5 have the synergistic effect. For the 20 MDRABs, whenthe Pithecellobium clypearia Benth water extract is smaller than orequal to the single-use MIC, the MIC₅₀ of the TE is reduced fromsingle-use 256 μg/ml to 64 μg/ml and is reduced by 75%; and the MIC₉₀ isreduced from 512 μg/ml to 128 μg/ml and is reduced by 75%.

For the 20 MDRABs, it is indicated by FIC≤2 with the combined use of thePithecellobium clypearia Benth water extract and the POLB that the twodrugs have no antagonistic effect, wherein 25% with FIC≤0.5 have thesynergistic effect. For the 20 MDRABs, when the Pithecellobium clypeariaBenth water extract is smaller than or equal to the single-use MIC, theMIC₅₀ of the POLB is reduced from single-use 4 μg/ml to 1 μg/ml and isreduced by 75%; and the MIC₉₀ is reduced from 16 μg/ml to 4 μg/ml and isreduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth water extract and the CAZ to the 20 MDRABs that the twodrugs have no antagonistic effect, wherein 20% with FIC≤0.5 have thesynergistic effect. When the Pithecellobium clypearia Benth waterextract is smaller than or equal to the single-use MIC, the MIC₅₀ of theCAZ is reduced from single-use 512 μg/ml to 128 μg/ml and is reduced by75%; and the MIC₉₀ is reduced from 512 μg/ml to 256 μg/ml and is reducedby 50%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth water extract and the LVX to the 20 MDRABs that the twodrugs have no antagonistic effect, wherein 35% with FIC≤0.5 show thatthe two drugs have a certain synergistic effect. For the 20 MDRAB, whenthe Pithecellobium clypearia Benth water extract is smaller than orequal to the single-use MIC, the MIC₅₀ of the LVX is reduced fromsingle-use 8 μg/ml to 2 μg/ml and is reduced by 75%; and the MIC₉₀ isreduced from 32 μg/ml to 8 μg/ml and is reduced by 75%.

2.2. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth 10% ethanol extract and the five antibiotics (the IMP, the TE, thePOLB, the CAZ and the LVX) to the MDRABs are shown in table A13.

In-vitro bactericidal test results of the Pithecellobium clypearia Benth10% ethanol extract to the MDRABs are shown in table A14.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth 10% ethanol extract and thefive antibiotics to the MDRABs is shown in table A15.

The statistic analysis on MBC₅₀ and MBC₉₀ of the EA to the MDRABs isshown in table A16.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth 10% ethanol extract and the five antibiotics anddistribution statistical results of the FIC values are shown in tableA17 and table A18.

The sensibilization effects of the Pithecellobium clypearia Benth 10%ethanol extract to the five antibiotics and the MIC₅₀ and MIC₉₀ aftercombined use are shown in tables A19-A24.

TABLE A13 In-vitro inhibitory test results of the Pithecellobiumclypearia Benth 10% ethanol extract and the five antibiotics to theMDRABs MIC (μg/ml) Strain No. EA IMP TE LVX CAZ POLB A1 600 1 2 0.5 1288 A2 600 32 256 16 512 2 A3 600 32 256 4 512 2 A4 600 8 8 0.5 256 2 A5600 32 32 4 64 4 A6 600 32 256 8 >512 8 A7 600 32 512 8 >512 4 A8 600 32256 4 512 8 A9 600 32 256 4 512 1 A10 600 16 128 32 512 32 A11 600 32256 4 512 16 A12 600 32 512 32 512 2 A13 600 32 512 32 256 2 A14 600 32256 16 512 0.5 A15 600 32 >512 32 256 2 A16 600 32 512 8 512 4 A17 60016 512 16 256 64 A18 600 32 512 8 512 4 A19 600 32 512 16 256 4 A20 60032 256 16 512 2 ATCC27853 300 1 8 1 4 1

TABLE A14 In-vitro bactericidal test results of the Pithecellobiumclypearia Benth 10% ethanol extract to the MDRABs Strain No. MBC (μg/ml)A1 1200 A2 1200 A3 1200 A4 1200 A5 1200 A6 1200 A7 1200 A8 1200 A9 1200A10 1200 A11 1200 A12 1200 A13 1200 A14 1200 A15 1200 A16 1200 A17 1200A18 1200 A19 1200 A20 1200

TABLE A15 Statistical results on in-vitro inhibitory MIC₅₀ and MIC₉₀ ofthe Pithecellobium clypearia Benth 10% ethanol extract and theantibiotics to the MDRABs MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 600 600600 IMP 1-32 32 32 TE  2-512 256 512 POLB 0.5-64  4 16 CAZ 64-512 512512 LVX 0.5-32  8 32

TABLE A16 bactericidal MBC₅₀ and MBC₉₀ of the Pithecellobium clypeariaBenth 10% ethanol extract to the MDRABs MBC (μg /ml) Drug Range MBC₅₀MBC₉₀ EA 1200 1200 1200

TABLE A17 FIC values of the combined drug sensitive test of thePithecellobium clypearia Benth 10% ethanol extract and the fiveantibiotics Strain FIC No. EA + IMP EA + TE EA + POLB EA + CAZ EA + LVXA1 1 1 1 1 0.625 A2 0.75 0.75 1 1 1 A3 0.75 0.75 1 1 0.625 A4 1.5 0.5 10.5 0.625 A5 0.5 0.375 0.75 1 1 A6 0.625 0.75 0.375 1 1 A7 0.5 0.5 0.3751 1 A8 1 0.5 0.507813 0.75 1 A9 0.375 0.375 0.5625 0.75 0.265625 A100.75 0.75 0.375 1 0.75 A11 0.5 0.5 1 0.75 1 A12 0.5 0.5 1 0.75 0.75 A130.5 1 1 1 0.75 A14 1 1 0.625 0.375 1 A15 0.75 0.625 1 1 1 A16 0.5 1 0.750.5 0.75 A17 0.75 0.375 0.75 0.5 0.5 A18 1 0.5 0.75 1 1 A19 0.5 1 0.750.5 0.375 A20 0.5 1.5 1 0.5 0.5

TABLE A18 Distribution statistics of the FIC values of the combined drugsensitive test of the Pithecellobium clypearia Benth 10% ethanol extractand the five antibiotics EA + EA + EA + EA + EA + FIC Range IMP TE POLBCAZ LVX FIC ≤ 0.5 45% 45% 15% 30% 20% 0.5 < FIC ≤ 1 50% 50% 85% 70% 80%1 < FIC ≤ 2  5%  5% — — — FIC > 2 — — — — —

TABLE A19 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the IMP and MIC after combined use EA EA IMP IMPStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 1 0.5 A2 600 300 32 8 A3600 300 32 8 A4 600 300 8 8 A5 600 150 32 8 A6 600 300 32 4 A7 600 15032 8 A8 600 300 32 16 A9 600 75 32 8 A10 600 150 16 8 A11 600 150 32 8A12 600 150 32 8 A13 600 150 32 8 A14 600 300 32 16 A15 600 300 32 8 A16600 150 32 8 A17 600 300 16 4 A18 600 300 32 16 A19 600 150 32 8 A20 600150 32 8

TABLE A20 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the TE and MIC after combined use EA EA TE TEStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 2 1 A2 600 300 256 64 A3600 300 256 64 A4 600 150 8 2 A5 600 150 32 4 A6 600 300 256 64 A7 600150 512 128 A8 600 150 256 64 A9 600 150 256 32 A10 600 300 128 32 A11600 150 256 64 A12 600 150 512 128 A13 600 300 512 256 A14 600 300 256128 A15 600 300 1024 128 A16 600 300 512 256 A17 600 150 512 64 A18 600150 512 128 A19 600 300 512 256 A20 600 300 256 256

TABLE A21 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the POLB and MIC after combined use EA EA POLBPOLB Strain single-use combined-use single-use combined-use No. MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 8 4 A2 600 300 21 A3 600 300 2 1 A4 600 300 2 1 A5 600 300 4 1 A6 600 150 8 1 A7 600 754 1 A8 600 300 8 0.0625 A9 600 300 1 0.0625 A10 600 150 32 4 A11 600 30016 8 A12 600 300 2 1 A13 600 300 2 1 A14 600 300 0.5 0.0625 A15 600 3002 1 A16 600 300 4 1 A17 600 300 64 16 A18 600 300 4 1 A19 600 300 4 1A20 600 300 2 1

TABLE A22 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the CAZ and MIC after combined use EA EA CAZ CAZStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 128 64 A2 600 300 512 256A3 600 300 512 256 A4 600 150 256 64 A5 600 300 64 32 A6 600 300 1024512 A7 600 300 1024 512 A8 600 150 512 256 A9 600 300 512 128 A10 600300 512 256 A11 600 300 512 128 A12 600 300 512 128 A13 600 300 256 128A14 600 150 512 64 A15 600 300 256 128 A16 600 150 512 128 A17 600 150256 64 A18 600 300 512 256 A19 600 150 256 64 A20 600 150 512 128

TABLE A23 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the LVX and MIC after combined use EA EA LVX LVXStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 0.5 0.0625 A2 600 300 168 A3 600 300 16 2 A4 600 300 0.5 0.0625 A5 600 300 4 2 A6 600 300 8 4 A7600 300 8 4 A8 600 300 4 2 A9 600 150 4 0.0625 A10 600 300 32 8 A11 600300 4 2 A12 600 300 32 8 A13 600 300 32 8 A14 600 300 16 8 A15 600 30032 16 A16 600 150 8 4 A17 600 150 16 4 A18 600 300 8 4 A19 600 150 16 2A20 600 150 16 4

TABLE A24 MIC₅₀ and MIC₉₀ of the five antibiotics after combined useAntibiotic (μg/ml) Combined drug MIC₅₀ after combined use MIC₉₀ aftercombined use EA + IMP 8 16 EA + TE 64 256 EA + POLB 1 4 EA + CAZ 128 256EA + LVX 4 8

With the single use of the Pithecellobium clypearia Benth 10% ethanolextract to the MDRABs, the MIC₅₀ is 600 μg/ml, the MIC₉₀ is 600 μg/ml,the MBC₅₀ is 1200 μg/ml, and the MBC₉₀ is 1200 μg/ml.

It is indicated by FIC≤1 with the combined use of the Pithecellobiumclypearia Benth 10% ethanol extract and the IMP that the two drugs havethe synergistic effect or partial synergistic effect, wherein 45% withFIC≤0.5 have the synergistic effect. For the 20 MDRABs, when theconcentration of the Pithecellobium clypearia Benth 10% ethanol extractis smaller than or equal to ½ of the single-use MIC, the MIC₅₀ of theIMP is reduced from single-use 32 μg/ml to 8 μg/ml and is reduced by75%; and the MIC₉₀ is reduced from 32 μg/ml to 16 μg/ml and is reducedby 50%.

It is indicated by FIC≤1 with the combined use of the Pithecellobiumclypearia Benth 10% ethanol extract and the TE to the 20 MDRABs that thetwo drugs have the synergistic effect or partial synergistic effect,wherein 45% with FIC≤0.5 have the synergistic effect. For the 20 MDRABs,when the Pithecellobium clypearia Benth 10% ethanol extract is smallerthan or equal to ½ of the single-use MIC, the MIC₅₀ of the TE is reducedfrom single-use 256 μg/ml to 64 μg/ml and is reduced by 75%; and theMIC₉₀ is reduced from 512 μg/ml to 256 μg/ml and is reduced by 50%.

For the 20 MDRABs, it is indicated by FIC≤2 with the combined use of thePithecellobium clypearia Benth 10% ethanol extract and the POLB that thetwo drugs have no antagonistic effect, wherein 15% with FIC≤0.5 have thesynergistic effect. For the 20 MDRABs, when the Pithecellobium clypeariaBenth 10% ethanol extract is smaller than or equal to the single-useMIC, the MIC₅₀ of the POLB is reduced from single-use 4 μg/ml to 1 μg/mland is reduced by 75%; and the MIC₉₀ is reduced from 16 μg/ml to 4 μg/mland is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 10% ethanol extract and the CAZ to the 20 MDRABs thatthe two drugs have no antagonistic effect, wherein 30% with FIC≤0.5 havethe synergistic effect. When an ethyl acetate extract of thePithecellobium clypearia Benth 10% ethanol extract is smaller than orequal to ½ of the single-use MIC, the MIC₅₀ of the CAZ is reduced fromsingle-use 512 μg/ml to 128 μg/ml and is reduced by 75%; and the MIC₉₀is reduced from 512 μg/ml to 256 μg/ml and is reduced by 50%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 10% ethanol extract and the LVX to the 20 MDRABs thatthe two drugs have no antagonistic effect, wherein 25% with FIC≤0.5 showthat the two drugs have a certain synergistic effect. For the 20 MDRABs,when the Pithecellobium clypearia Benth 10% ethanol extract is smallerthan or equal to the single-use MIC, the MIC₅₀ of the LVX is reducedfrom single-use 8 μg/ml to 4 μg/ml and is reduced by 50%; and the MIC₉₀is reduced from 32 μg/ml to 8 μg/ml and is reduced by 75%.

2.3. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth 60% ethanol extract and the five antibiotics (the IMP, the TE, thePOLB, the CAZ and the LVX) to the MDRABs are shown in table A25.

In-vitro bactericidal test results of the Pithecellobium clypearia Benth60% ethanol extract to the MDRABs are shown in table A26.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth 60% ethanol extract and thefive antibiotics to the MDRABs is shown in table A27.

The statistic analysis on MBC₅₀ and MBC₉₀ of the EA to the MDRABs isshown in table A28.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth 60% ethanol extract and the five antibiotics anddistribution statistical results of the FIC values are shown in tableA29 and table A30.

The sensibilization effects of the Pithecellobium clypearia Benth 60%ethanol extract to the five antibiotics and the MIC₅₀ and MIC₉₀ aftercombined use are shown in tables A31-A36.

TABLE A25 In-vitro inhibitory test results of the Pithecellobiumclypearia Benth 60% ethanol extract and the five antibiotics to theMDRABs MIC (μg/ml) Strain No. EA IMP TE LVX CAZ POLB A1 300 1 2 0.5 1288 A2 300 32 256 16 512 2 A3 600 32 256 4 512 2 A4 600 8 8 0.5 256 2 A5300 32 32 4 64 4 A6 300 32 256 8 >512 8 A7 300 32 512 8 >512 4 A8 300 32256 4 512 8 A9 600 32 256 4 512 1 A10 300 16 128 32 512 32 A11 600 32256 4 512 16 A12 300 32 512 32 512 2 A13 300 32 512 32 256 2 A14 600 32256 16 512 0.5 A15 600 32 >512 32 256 2 A16 300 32 512 8 512 4 A17 30016 512 16 256 64 A18 300 32 512 8 512 4 A19 300 32 512 16 256 4 A20 30032 256 16 512 2 ATCC27853 300 1 8 1 4 1

TABLE A26 In-vitro bactericidal test results of the Pithecellobiumclypearia Benth 60% ethanol extract to the MDRABs Strain No. MBC (μg/ml)A1 600 A2 600 A3 1200 A4 1200 A5 600 A6 600 A7 600 A8 1200 A9 600 A10600 A11 600 A12 600 A13 600 A14 1200 A15 1200 A16 1200 A17 600 A18 600A19 600 A20 600

TABLE A27 Statistics on in-vitro inhibitory MIC₅₀ and MIC₉₀ of thePithecellobium clypearia Benth 60% ethanol extract and the antibioticsto the MDRABs MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 300-600  300 600 IMP1-32 32 32 TE  2-512 256 512 POLB 0.5-64  4 16 CAZ 64-512 512 512 LVX0.5-32  8 32

TABLE A28 Bactericidal MBC₅₀ and MIC₉₀ of the Pithecellobium clypeariaBenth 60% ethanol extract to the MDRABs MBC (μg/ml) Drug Range MBC₅₀MBC₉₀ EA 600-1200 600 1200

TABLE A29 FIC values of the combined drug sensitive test of thePithecellobium clypearia Benth 60% ethanol extract and the fiveantibiotics Strain FIC No. EA + IMP EA + TE EA + POLB EA + CAZ EA + LVXA1 0.75 0.75 1.5 0.75 0.375 A2 0.5 0.5 1.25 0.75 1.25 A3 0.375 0.375 10.5 1.0040 A4 0.1875 0.625 0.75 0.5 0.625 A5 0.5 0.75 1 0.75 1.25 A60.625 0.75 0.5 1 1 A7 0.625 0.75 0.75 0.75 1 A8 0.625 0.625 1.0080 0.751.25 A9 0.375 0.375 0.5625 0.625 0.5156 A10 0.75 0.75 0.5 0.75 1.0020A11 0.375 0.375 0.5 0.625 1.125 A12 0.3125 0.5 1.25 0.75 1.03125 A13 0.50.5 1.5 1 1.0020 A14 0.25 0.375 0.625 0.625 0.625 A15 0.375 0.31250.53125 0.75 0.5020 A16 0.5 0.5 1.0156 0.75 0.75 A17 0.625 1 1.031250.75 0.75 A18 0.5 0.625 1.125 0.75 0.75 A19 0.375 0.5 1.125 1 1 A20 0.50.625 1.25 1 1

TABLE A30 Distribution statistics of the FIC values of the combined drugsensitive test of the Pithecellobium clypearia Benth 60% ethanol extractand the five antibiotics EA + EA + EA + EA + EA + FIC Range IMP TE POLBCAZ LVX FIC ≤ 0.5 70% 50% 15% 10%  5% 0.5 < FIC ≤ 1 30% 50% 35% 85% 55%1 < FIC ≤ 2 — — 50%  5% 40% FIC > 2 — — — — —

TABLE A31 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the IMP and MIC after combined use EA EA IMP IMPStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 300 75 1 0.5 A2 300 75 32 8 A3600 75 32 8 A4 600 75 8 0.5 A5 300 75 32 8 A6 300 37.5 32 16 A7 300 37.532 16 A8 300 37.5 32 16 A9 600 150 32 4 A10 300 75 16 8 A11 600 150 32 4A12 300 18.75 32 8 A13 300 75 32 8 A14 600 75 32 4 A15 600 150 32 4 A16300 75 32 8 A17 300 150 16 2 A18 300 75 32 8 A19 300 37.5 32 8 A20 30075 32 8

TABLE A32 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the TE and MIC after combined use EA EA TE TEStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 300 75 2 1 A2 300 75 256 64 A3600 150 256 32 A4 600 300 8 1 A5 300 150 32 8 A6 300 75 256 128 A7 300150 512 128 A8 300 150 256 32 A9 600 150 256 32 A10 300 150 128 32 A11600 150 256 32 A12 300 75 512 128 A13 300 75 512 128 A14 600 150 256 32A15 600 150 1024 64 A16 300 75 512 128 A17 300 150 512 256 A18 300 150512 64 A19 300 75 512 128 A20 300 150 256 32

TABLE A33 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the POLB and MIC after combined use EA EA POLBPOLB Strain single-use combined-use single-use combined-use No. MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 300 300 8 4 A2 300 300 20.5 A3 600 300 2 1 A4 600 150 2 1 A5 300 150 4 2 A6 300 75 8 2 A7 300 754 2 A8 300 300 8 0.0625 A9 600 300 1 0.0625 A10 300 75 32 8 A11 600 15016 4 A12 300 300 2 0.5 A13 300 300 2 1 A14 600 300 0.5 0.0625 A15 600300 2 0.0625 A16 300 300 4 0.0625 A17 300 300 64 2 A18 300 300 4 0.5 A19300 300 4 0.5 A20 300 300 2 0.5

TABLE A34 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the CAZ and MIC after combined use EA EA CAZ CAZStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 300 75 128 64 A2 300 150 512 128A3 600 150 512 128 A4 600 150 256 64 A5 300 75 64 32 A6 300 150 1024 512A7 300 150 1024 256 A8 300 75 512 256 A9 600 300 512 64 A10 300 150 512128 A11 600 300 512 64 A12 300 150 512 128 A13 300 150 256 128 A14 60075 512 256 A15 600 150 256 128 A16 300 150 512 128 A17 300 75 256 128A18 300 150 512 128 A19 300 150 256 128 A20 300 150 512 256

TABLE A35 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the LVX and MIC after combined use EA EA LVX LVXStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 300 75 0.5 0.0625 A2 300 75 16 16A3 300 300 16 0.0625 A4 600 300 0.5 0.0625 A5 300 75 4 4 A6 300 150 8 4A7 300 150 8 4 A8 300 75 4 4 A9 600 300 4 0.0625 A10 300 300 32 0.0625A11 600 75 4 4 A12 300 300 32 1 A13 300 300 32 0.0625 A14 600 75 16 8A15 600 300 32 0.0625 A16 300 75 8 4 A17 300 150 16 4 A18 300 75 8 4 A19300 150 16 8 A20 300 150 16 8

TABLE A36 MIC₅₀ and MIC₉₀ of the five antibiotics after combined useAntibiotic (μg/ml) Combined drug MIC₅₀ after combined use MIC₉₀ aftercombined use EA + IMP 8 16 EA + TE 32 128 EA + POLB 0.5 4 EA + CAZ 128256 EA + LVX 4 8

With the single use of the Pithecellobium clypearia Benth 60% ethanolextract to the MDRABs, the MIC₅₀ is 300 μg/ml, the MIC₉₀ is 600 μg/ml,the MBC₅₀ is 600 μg/ml, and the MBC₉₀ is 1200 μg/ml.

It is indicated by FIC≤1 with the combined use of the Pithecellobiumclypearia Benth 60% ethanol extract and the IMP that the two drugs havethe synergistic effect or partial synergistic effect, wherein 70% withFIC≤0.5 have the synergistic effect. For the 20 MDRABs, when theconcentration of the Pithecellobium clypearia Benth 60% ethanol extractis smaller than or equal to ½ of the single-use MIC, the MIC₅₀ of theIMP is reduced from single-use 32 μg/ml to 8 μg/ml and is reduced by75%; and the MIC₉₀ is reduced from 32 μg/ml to 16 μg/ml and is reducedby 50%.

It is indicated by FIC≤1 with the combined use of the Pithecellobiumclypearia Benth 60% ethanol extract and the TE to the 20 MDRABs that thetwo drugs have the synergistic effect or partial synergistic effect,wherein 50% with FIC≤0.5 have the synergistic effect. For the 20 MDRABs,when the Pithecellobium clypearia Benth 60% ethanol extract is smallerthan or equal to ½ of the single-use MIC, the MIC₅₀ of the TE is reducedfrom single-use 256 μg/ml to 32 μg/ml and is reduced by 87.5%; and theMIC₉₀ is reduced from 512 μg/ml to 128 μg/ml and is reduced by 75%.

For the 20 MDRABs, it is indicated by FIC≤2 with the combined use of thePithecellobium clypearia Benth 60% ethanol extract and the POLB that thetwo drugs have no antagonistic effect, wherein 15% with FIC≤0.5 have thesynergistic effect. For the 20 MDRABs, when the Pithecellobium clypeariaBenth 60% ethanol extract is smaller than or equal to the single-useMIC, the MIC₅₀ of the POLB is reduced from single-use 4 μg/ml to 0.5μg/ml and is reduced by 87.5%; and the MIC₉₀ is reduced from 16 μg/ml to4 μg/ml and is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 60% ethanol extract and the CAZ to the 20 MDRABs thatthe two drugs have no antagonistic effect, wherein 10% with FIC≤0.5 havethe synergistic effect. When the Pithecellobium clypearia Benth 60%ethanol extract is smaller than or equal to ½ of the single-use MIC, theMIC₅₀ of the CAZ is reduced from single-use 512 μg/ml to 128 μg/ml andis reduced by 75%; and the MIC₉₀ is reduced from 512 μg/ml to 256 μg/mland is reduced by 50%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 60% ethanol extract and the LVX to the 20 MDRABs thatthe two drugs have no antagonistic effect, wherein 5% with FIC≤0.5 showthat the two drugs have a certain synergistic effect. For the 20 MDRABs,when the Pithecellobium clypearia Benth 60% ethanol extract is smallerthan or equal to the single-use MIC, the MIC₅₀ of the LVX is reducedfrom single-use 8 μg/ml to 4 μg/ml and is reduced by 50%; and the MIC₉₀is reduced from 32 μg/ml to 8 μg/ml and is reduced by 75%.

2.4. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth 95% ethanol extract and the five antibiotics (the IMP, the TE, thePOLB, the CAZ and the LVX) to the MDRABs are shown in table A37.

In-vitro bactericidal test results of the Pithecellobium clypearia Benth95% ethanol extract to the MDRABs are shown in table A38.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth 95% ethanol extract and thefive antibiotics to the MDRABs is shown in table A39.

The statistic analysis on MBC₅₀ and MBC₉₀ of the EA to the MDRABs isshown in table A40.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth 95% ethanol extract and the five antibiotics anddistribution statistical results of the FIC values are shown in tableA41 and table A42.

The sensibilization effects of the Pithecellobium clypearia Benth 95%ethanol extract to the five antibiotics and the MIC₅₀ and MIC₉₀ aftercombined use are shown in tables A43-A48.

TABLE A37 In-vitro inhibitory test results of the Pithecellobiumclypearia Benth 95% ethanol extract and the five antibiotics to theMDRABs MIC (μg/ml) Strain No. EA IMP TE LVX CAZ POLB A1 600 1 2 0.5 1288 A2 600 32 256 16 512 2 A3 600 32 256 4 512 2 A4 600 8 8 0.5 256 2 A5600 32 32 4 64 4 A6 600 32 256 8 >512 8 A7 600 32 512 8 >512 4 A8 600 32256 4 512 8 A9 600 32 256 4 512 1 A10 600 16 128 32 512 32 A11 600 32256 4 512 16 A12 600 32 512 32 512 2 A13 600 32 512 32 256 2 A14 600 32256 16 512 0.5 A15 1200 32 >512 32 256 2 A16 600 32 512 8 512 4 A17 60016 512 16 256 64 A18 600 32 512 8 512 4 A19 600 32 512 16 256 4 A20 60032 256 16 512 2 ATCC27853 300 1 8 1 4 1

TABLE A38 In-vitro bactericidal test results of the Pithecellobiumclypearia Benth 95% ethanol extract to the MDRABs Strain No. MBC (μg/ml)A1 1200 A2 1200 A3 1200 A4 1200 A5 1200 A6 1200 A7 1200 A8 1200 A9 1200A10 1200 A11 1200 A12 1200 A13 1200 A14 1200 A15 1200 A16 1200 A17 1200A18 1200 A19 1200 A20 1200

TABLE A39 Statistical results on in-vitro inhibitory MIC₅₀ and MIC₉₀ ofthe Pithecellobium clypearia Benth 95% ethanol extract and theantibiotics to the MDRABs MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 600-1200600 600 IMP 1-32 32 32 TE  2-512 256 512 POLB 0.5-64  4 16 CAZ 64-512512 512 LVX 0.5-32  8 32

TABLE A40 Bactericidal MBC₅₀ and MBC₉₀ of the Pithecellobium clypeariaBenth 95% ethanol extract to the MDRABs MBC (μg/ml) Drug Range MBC₅₀MBC₉₀ EA 1200 1200 1200

TABLE A41 FIC values of the combined drug sensitive test of thePithecellobium clypearia Benth 95% ethanol extract and the fiveantibiotics Strain FIC No. EA + IMP EA + TE EA + POLB EA + CAZ EA + LVXA1 0.75 0.75 1 1 1 A2 0.5 0.5 0.75 0.75 1 A3 0.5 0.375 1 0.75 0.625 A40.3125 0.625 1 0.75 0.375 A5 0.75 0.5 1 1 1 A6 0.75 1 0.5 1 1 A7 0.750.75 0.75 0.5 1 A8 0.75 0.625 0.625 1 1 A9 0.375 0.625 0.75 1 0.515625A10 0.75 0.75 0.5 1 0.3125 A11 0.375 0.625 0.5 0.625 1.5 A12 0.5 0.75 10.75 0.53125 A13 0.75 0.5 1 0.75 0.5625 A14 0.75 0.375 1 1 1 A15 0.750.3125 0.28125 0.75 0.3125 A16 0.5 0.75 0.515625 1 0.75 A17 0.375 0.750.5625 1 0.5 A18 0.5 0.75 0.75 0.5 1 A19 0.5 0.75 0.75 0.75 1 A20 0.50.625 0.75 1 0.75

TABLE A42 Distribution statistics of the FIC values of the combined drugsensitive test of the Pithecellobium clypearia Benth 95% ethanol extractand the five antibiotics EA + EA + EA + EA + EA + FIC Range IMP TE POLBCAZ LVX FIC ≤ 0.5 55% 30% 20% 10% 20% 0.5 < FIC ≤ 1 45% 70% 80% 90% 75%1 < FIC ≤ 2 — — — —  5% FIC > 2 — — — — —

TABLE A43 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the IMP and MIC after combined use EA EA IMP IMPStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 150 1 0.5 A2 600 150 32 8 A3600 150 32 8 A4 600 150 8 0.5 A5 600 300 32 8 A6 600 150 32 16 A7 600150 32 16 A8 600 150 32 16 A9 600 150 32 4 A10 600 150 16 8 A11 600 15032 4 A12 600 150 32 8 A13 600 300 32 8 A14 600 300 32 8 A15 1200 600 328 A16 600 150 32 8 A17 600 150 16 2 A18 600 150 32 8 A19 600 150 32 8A20 600 150 32 8

TABLE A44 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the TE and MIC after combined use EA EA TE TEStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 150 2 1 A2 600 150 256 64 A3600 150 256 32 A4 600 300 8 1 A5 600 150 32 8 A6 600 300 256 128 A7 600300 512 128 A8 600 300 256 32 A9 600 300 256 32 A10 600 300 128 32 A11600 300 256 32 A12 600 300 512 128 A13 600 150 512 128 A14 600 150 25632 A15 1200 300 1024 64 A16 600 300 512 128 A17 600 300 512 128 A18 600300 512 128 A19 600 300 512 128 A20 600 300 256 32

TABLE A45 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the POLB and MIC after combined use EA EA POLBPOLB Strain single-use combined-use single-use combined-use No. MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 8 4 A2 600 300 20.5 A3 600 300 2 1 A4 600 300 2 1 A5 600 300 4 2 A6 600 150 8 2 A7 600150 4 2 A8 600 300 8 1 A9 600 300 1 0.25 A10 600 150 32 8 A11 600 150 164 A12 600 300 2 1 A13 600 300 2 1 A14 600 300 0.5 0.25 A15 1200 300 20.0625 A16 600 300 4 0.0625 A17 600 300 64 4 A18 600 300 4 1 A19 600 3004 1 A20 600 300 2 0.5

TABLE A46 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the CAZ and MIC after combined use EA EA CAZ CAZStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 128 64 A2 600 300 512 128A3 600 300 512 128 A4 600 300 256 64 A5 600 300 64 32 A6 600 300 1024512 A7 600 150 1024 256 A8 600 300 512 256 A9 600 300 512 256 A10 600300 512 256 A11 600 300 512 64 A12 600 300 512 128 A13 600 150 256 128A14 600 300 512 256 A15 1200 300 256 128 A16 600 300 512 256 A17 600 300256 128 A18 600 150 512 128 A19 600 150 256 128 A20 600 300 512 256

TABLE A47 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the LVX and MIC after combined use EA EA LVX LVXStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) A1 600 300 0.5 0.25 A2 600 300 16 8A3 600 300 16 2 A4 600 150 0.5 0.0625 A5 600 300 4 2 A6 600 300 8 4 A7600 300 8 4 A8 600 300 4 2 A9 600 300 4 0.0625 A10 600 150 32 2 A11 600300 4 4 A12 600 300 32 1 A13 600 300 32 2 A14 600 300 16 8 A15 1200 30032 2 A16 600 150 8 4 A17 600 150 16 4 A18 600 300 8 4 A19 600 300 16 8A20 600 150 16 8

TABLE A48 MIC₅₀ and MIC₉₀ of the five antibiotics after combined useAntibiotic (μg/ml) Combined drug MIC₅₀ after combined use MIC₉₀ aftercombined use EA + IMP 8 16 EA + TE 32 128 EA + POLB 1 4 EA + CAZ 128 256EA + LVX 4 8

With the single use of the Pithecellobium clypearia Benth 95% ethanolextract to the MDRABs, the MIC₅₀ is 600 μg/ml, the MIC₉₀ is 600 μg/ml,the MBC₅₀ is 1200 μg/ml, and the MBC₉₀ is 1200 μg/ml.

It is indicated by FIC≤1 with the combined use of the Pithecellobiumclypearia Benth 95% ethanol extract and the IMP that the two drugs havethe synergistic effect or partial synergistic effect, wherein 55% withFIC≤0.5 have the synergistic effect. For the 20 MDRABs, when theconcentration of the Pithecellobium clypearia Benth 95% ethanol extractis smaller than or equal to the single-use MIC, the MIC₅₀ of the IMP isreduced from single-use 32 μg/ml to 8 μg/ml and is reduced by 75%; andthe MIC₉₀ is reduced from 32 μg/ml to 16 μg/ml and is reduced by 50%.

It is indicated by FIC≤1 with the combined use of the Pithecellobiumclypearia Benth 95% ethanol extract and the TE to the 20 MDRABs that thetwo drugs have the synergistic effect or partial synergistic effect,wherein 35% with FIC≤0.5 have the synergistic effect. For the 20 MDRABs,when the Pithecellobium clypearia Benth 95% ethanol extract is smallerthan or equal to the single-use MIC, the MIC₅₀ of the TE is reduced fromsingle-use 256 μg/ml to 32 μg/ml and is reduced by 87.5%; and the MIC₉₀is reduced from 512 μg/ml to 128 μg/ml and is reduced by 75%.

For the 20 MDRABs, it is indicated by FIC≤2 with the combined use of thePithecellobium clypearia Benth 95% ethanol extract and the POLB that thetwo drugs have no antagonistic effect, wherein 20% with FIC≤0.5 have thesynergistic effect. For the 20 MDRABs, when the Pithecellobium clypeariaBenth 95% ethanol extract is smaller than or equal to the single-useMIC, the MIC₅₀ of the POLB is reduced from single-use 4 μg/ml to 1 μg/mland is reduced by 75%; and the MIC₉₀ is reduced from 16 μg/ml to 4 μg/mland is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 95% ethanol extract and the CAZ to the 20 MDRABs thatthe two drugs have no antagonistic effect, wherein 10% with FIC≤0.5 havethe synergistic effect. When the Pithecellobium clypearia Benth 95%ethanol extract is smaller than or equal to the single-use MIC, theMIC₅₀ of the CAZ is reduced from single-use 512 μg/ml to 128 μg/ml andis reduced by 75%; and the MIC₉₀ is reduced from 512 μg/ml to 256 μg/mland is reduced by 50%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 95% ethanol extract and the LVX to the 20 MDRABs thatthe two drugs have no antagonistic effect, wherein 20% with FIC≤0.5 showthat the two drugs have a certain synergistic effect. For the 20 MDRABs,when the Pithecellobium clypearia Benth 95% ethanol extract is smallerthan or equal to the single-use MIC, the MIC₅₀ of the LVX is reducedfrom single-use 8 μg/ml to 4 μg/ml and is reduced by 50%; and the MIC₉₀is reduced from 32 μg/ml to 8 μg/ml and is reduced by 75%.

II. Inhibitory and bactericidal tests of the MDRPA resistance of the EAand test of the sensibilization effect by respectively using with theLVX, the IMP, the AMK, the CAZ and the CFP

Embodiment 2

1. Test method: the MDRPA (serial No.: P1-P20) strains are tested andare evaluated with reference to the method in the first embodiment.

2. Test Results:

2.1. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth water extract and the five antibiotics (the LVX, the IMP, the AMK,the CAZ and the CFP) to the MDRPAs are shown in table P1.

In-vitro bactericidal test results of the Pithecellobium clypearia Benthwater extract to the MDRPAs are shown in table P2.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the EA and the five antibiotics to the MDRPAs is shown in tableP3.

The statistic analysis on MBC₅₀ and MBC₉₀ of the EA to the MDRPAs isshown in table P4.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth water extract and the five antibiotics and distributionstatistical results of the FIC values are shown in table P5 and tableP6.

The sensibilization effects of the Pithecellobium clypearia Benth waterextract to the five antibiotics and the MIC₅₀ and MIC₉₀ after combineduse are shown in tables P7-P12.

TABLE P1 In-vitro inhibitory test results of the Pithecellobiumclypearia Benth water extract and the five antibiotics to the MDRPAs MIC(μg/ml) Strain No. EA LVX IMP AMK CAZ CFP P1 800 32 32 1 32 128 P2 800 464 1 64 256 P3 800 8 64 4 4 16 P4 800 8 32 1 256 8 P5 800 1 64 2 64 512P6 1600 0.5 32 256 512 512 P7 800 32 32 1 64 512 P8 1600 1 64 1 256 16P9 800 4 32 1 8 64 P10 800 128 64 4 4 8 P11 800 2 8 1 2 8 P12 800 1 3232 64 512 P13 800 2 8 2 16 256 P14 800 32 32 2 16 8 P15 800 2 32 2 25664 P16 1600 32 16 256 32 >512 P17 800 4 16 1 32 16 P18 800 4 32 16 64256 P19 800 16 64 1 4 64 P20 800 4 4 2 256 >512 ATCC27853 400 1 4 2 4 8

TABLE P2 In-vitro bactericidal test results of the Pithecellobiumclypearia Benth water extract to the MDRPAs Strain No. MBC (μg/ml) P11600 P2 1600 P3 1600 P4 1600 P5 1600 P6 1600 P7 1600 P8 1600 P9 1600 P101600 P11 1600 P12 1600 P13 1600 P14 3200 P15 1600 P16 1600 P17 1600 P181600 P19 3200 P20 1600

TABLE P3 Statistical results on in-vitro inhibitory MIC₅₀ and MIC₉₀ ofthe Pithecellobium clypearia Benth water extract and the fiveantibiotics to the MDRPAs MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA800-1600  800 1600 CAZ 2-512 32 256 CFP 8-512 64 512 AMK 1-256 1 32 IMP4-64  32 64 LVX 0.5-128  4 32

TABLE P4 Bactericidal MBC₅₀ and MBC₉₀ of the Pithecellobium clypeariaBenth water extract to the MDRPAs MBC (μg/ml) Drug Range MBC₅₀ MBC₉₀ EA1600-3200 1600 1600

TABLE P5 FIC values of the combined drug sensitive test of thePithecellobium clypearia Benth water extract and the five antibioticsFIC Strain EA + EA + EA + EA + EA + No. CAZ CFP AMK IMP LVX P1 0.5 0.3750.5625 1 0.625 P2 0.5 1 0.1875 0.28125 0.507813 P3 0.75 0.375 0.3750.28125 0.503906 P4 0.5 1 1.5 1.0625 0.75 P5 1 0.75 1.03125 0.5 0.53125P6 0.625 0.75 0.75 0.5625 0.3125 P7 0.75 0.53125 0.5625 1.0625 1.000977P8 0.375 0.15625 0.75 0.28125 0.28125 P9 1 1 0.5625 1 1 P10 1 0.56250.375 0.5 0.375 P11 1 0.75 1 0.75 1 P12 0.53125 0.250977 0.3125 0.5625 1P13 0.5 0.375 0.28125 0.5 1 P14 1 0.5625 0.53125 0.625 1.03125 P15 1 0.50.53125 0.5 1.5 P16 0.5 0.375 0.250244 0.375 0.5625 P17 0.5 0.531250.5625 0.75 2 P18 0.5 0.75 0.5 0.625 2.03125 P19 1 0.507813 0.56250.5625 0.75 P20 0.5 0.500488 0.625 1 0.75

TABLE P6 Distribution statistical results of the FIC values of thecombined drug sensitive test of the Pithecellobium clypearia Benth waterextract and the five antibiotics EA + EA + EA + EA + EA + FIC Range CAZCFP AMK IMP LVX FIC ≤ 0.5 45% 35% 35% 40% 15% 0.5 < FIC ≤ 1 55% 65% 55%50% 60% 1 < FIC ≤ 2 — — 10% 10% 25% FIC > 2 — — — — —

TABLE P7 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the CAZ and MIC after combined use EA EA CAZ CAZ Strainsingle-use combined-use single-use combined-use No. MIC (μg/ml) MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 200 32 8 P2 800 200 64 16 P3 800200 4 2 P4 800 200 256 64 P5 800 400 64 32 P6 1600 200 512 256 P7 800200 64 32 P8 1600 200 256 64 P9 800 400 8 4 P10 800 400 4 2 P11 800 4002 1 P12 800 400 64 2 P13 800 200 16 4 P14 800 400 16 8 P15 800 400 256128 P16 1600 400 32 8 P17 800 200 32 8 P18 800 200 64 16 P19 800 400 4 2P20 800 200 256 64

TABLE P8 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the CFP and MIC after combined use EA EA CFP CFP Strainsingle-use combined-use single-use combined-use No. MIC (μg/ml) MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 100 128 32 P2 800 400 256 128 P3800 200 16 2 P4 800 400 8 4 P5 800 200 512 256 P6 1600 400 512 256 P7800 400 512 16 P8 1600 200 16 0.5 P9 800 400 64 32 P10 800 400 8 0.5 P11800 200 8 4 P12 800 200 512 0.5 P13 800 200 256 32 P14 800 400 8 0.5 P15800 200 64 16 P16 1600 200 1024 256 P17 800 400 16 0.5 P18 800 200 256128 P19 800 400 64 0.5 P20 800 400 1024 0.5

TABLE P9 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the AMK and MIC after combined use EA EA AMK AMK Strainsingle-use combined-use single-use combined-use No. MIC (μg/ml) MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 400 1 0.0625 P2 800 100 1 0.0625P3 800 100 4 1 P4 800 800 1 0.5 P5 800 800 2 0.0625 P6 1600 800 256 64P7 800 400 1 0.0625 P8 1600 400 1 0.5 P9 800 400 1 0.0625 P10 800 100 41 P11 800 400 1 0.5 P12 800 50 32 8 P13 800 200 2 0.0625 P14 800 400 20.0625 P15 800 400 2 0.0625 P16 1600 400 256 0.0625 P17 800 400 1 0.0625P18 800 200 16 4 P19 800 400 1 0.0625 P20 800 100 2 1

TABLE P10 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the IMP and MIC after combined use EA EA IMP IMP Strainsingle-use combined-use single-use combined-use No. MIC (μg/ml) MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 400 32 16 P2 800 200 64 2 P3 800200 64 2 P4 800 800 32 2 P5 800 200 64 16 P6 1600 800 32 2 P7 800 800 322 P8 1600 400 64 2 P9 800 400 32 16 P10 800 200 64 16 P11 800 200 8 4P12 800 400 32 2 P13 800 200 8 2 P14 800 400 32 4 P15 800 200 32 8 P161600 400 16 2 P17 800 400 16 4 P18 800 400 32 4 P19 800 400 64 4 P20 800400 4 2

TABLE P11 Sensibilization effect of the Pithecellobium clypearia Benthwater extract to the LVX and MIC after combined use EA EA LVX LVX Strainsingle-use combined-use single-use combined-use No. MIC (μg/ml) MIC(μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 400 32 4 P2 800 400 4 0.03125 P3800 400 8 0.03125 P4 800 200 8 4 P5 800 400 1 0.03125 P6 1600 400 0.50.03125 P7 800 800 32 0.03125 P8 1600 400 1 0.03125 P9 800 400 4 2 P10800 100 128 32 P11 800 400 2 1 P12 800 400 1 0.5 P13 800 400 2 1 P14 800800 32 1 P15 800 800 2 1 P16 1600 800 32 2 P17 800 800 4 4 P18 800 25 48 P19 800 400 16 4 P20 800 400 4 1

TABLE P12 MIC₅₀ and MIC₉₀ of the five antibiotics after combined useAntibiotic (μg/ml) Combined drug MIC₅₀ after combined use MIC₉₀ aftercombined use EA + CAZ 8 64 EA + CFP 0.5 256 EA + AMK 0.0625 2 EA + IMP 216 EA + LVX 1 8

With the single use of the EA to the MDRPA, the MIC₅₀ is 800 μg/ml, theMIC₉₀ is 1600 μg/ml, the MBC₅₀ is 1600 μg/ml, and the MBC₉₀ is 1600μg/ml.

For the 20 MDRPAs, it is indicated by FIC≤2 with the combined use of theEA and the CAZ that the two drugs have no antagonistic effect, wherein45% with FIC≤0.5 have the synergistic effect. For the 20 MDRPAs, whenthe concentration of the EA is smaller than or equal to the single-useMIC, the MIC₅₀ of the CAZ is reduced from single-use 32 μg/ml to 8 μg/mland is reduced by 75%; and the MIC₉₀ is reduced from 256 μg/ml to 64μg/ml and is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the EA and the CFP tothe 20 MDRPAs that the two drugs have no antagonistic effect, wherein35% with FIC≤0.5 have the synergistic effect. For the 20 MDRPAs, whenthe concentration of the EA is smaller than or equal to the single-useMIC, the MIC₅₀ of the CFP is reduced from single-use 64 μg/ml to 0.5μg/ml and is reduced by 99.2%; and the MIC₉₀ is reduced from 512 μg/mlto 256 μg/ml and is reduced by 50%.

It is indicated by FIC≤2 with the combined use of the EA and the AMKthat the two drugs have no antagonistic effect, wherein 35% with FIC≤0.5have the synergistic effect. For the 20 MDRPAs, when the concentrationof the EA is smaller than or equal to the single-use MIC, the MIC₅₀ ofthe AMK is reduced from single-use 1 μg/ml to 0.0625 μg/ml and isreduced by 93.75%; and the MIC₉₀ is reduced from 32 μg/ml to 2 μg/ml andis reduced by 93.75%.

It is indicated by FIC≤2 with the combined use of the EA and the IMPthat the two drugs have no antagonistic effect, wherein 40% with FIC≤0.5have the synergistic effect. For the 20 MDRPAs, when the concentrationof the EA is smaller than or equal to the single-use MIC, the MIC₅₀ ofthe IMP is reduced from single-use 32 μg/ml to 2 μg/ml and is reduced by93.75%; and the MIC₉₀ is reduced from 64 μg/ml to 16 μg/ml and isreduced by 75%.

It is indicated by FIC≤2 with the combined use of the EA and the LVX tothe 20 MDRPAs that the two drugs have no antagonistic effect, wherein15% with FIC≤0.5 show that the two drugs have a certain synergisticeffect. For the 20 MDRPA, when the concentration of the EA is smallerthan or equal to the single-use MIC, the MIC₅₀ of the LVX is reducedfrom single-use 4 μg/ml to 1 μg/ml and is reduced by 75%; and the MIC₉₀is reduced from 32 μg/ml to 8 μg/ml and is reduced by 75%.

2.2. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth 10% ethanol extract and the five antibiotics (the LVX, the IMP,the AMK, the CAZ and the CFP) to the MDRPAs are shown in table P13.

In-vitro bactericidal test results of the Pithecellobium clypearia Benth10% ethanol extract to the MDRPAs are shown in table P14.

According to statistic analysis, the in-vitro inhibitory andbactericidal MBC₅₀ and MBC₉₀ of the Pithecellobium clypearia Benth 10%ethanol extract and the five antibiotics to the MDRPAs are shown intable P15.

According to statistic analysis, the bactericidal MBC₅₀ and MBC₉₀ of theEA to the MDRPAs are shown in table P16.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth 10% ethanol extract and the five antibiotics anddistribution statistical results of the FIC values are shown in tableP17 and table P18.

The sensibilization effects of the Pithecellobium clypearia Benth 10%ethanol extract to the five antibiotics and the MIC₅₀ and MIC₉₀ aftercombined use are shown in tables P19-P24.

TABLE P13 In-vitro inhibitory test results of the Pithecellobiumclypearia Benth 10% ethanol extract and the five antibiotics to theMDRPAs MIC(μg/ml) Strain No. EA LVX IMP AMK CAZ CFP P1 800 32 32 1 32128 P2 800 4 64 1 64 256 P3 800 8 64 4 4 16 P4 800 8 32 1 256 8 P5 800 164 2 64 512 P6 800 0.5 32 256 512 512 P7 800 32 32 1 64 512 P8 1600 1 641 256 16 P9 800 4 32 1 8 64 P10 800 128 64 4 4 8 P11 800 2 8 1 2 8 P12800 1 32 32 64 512 P13 800 2 8 2 16 256 P14 800 32 32 2 16 8 P15 800 232 2 256 64 P16 1600 32 16 256 32 >512 P17 800 4 16 1 32 16 P18 800 4 3216 64 256 P19 800 16 64 1 4 64 P20 800 4 4 2 256 >512 ATCC27853 400 1 42 4 8

TABLE P14 In-vitro bactericidal test results of the Pithecellobiumclypearia Benth 10% ethanol extract to the MDRPAs Strain No. MBC (μg/ml)P1 1600 P2 1600 P3 1600 P4 1600 P5 1600 P6 1600 P7 1600 P8 1600 P9 1600P10 1600 P11 1600 P12 1600 P13 1600 P14 1600 P15 1600 P16 1600 P17 1600P18 1600 P19 3200 P20 1600

TABLE P15 Statistical results on in-vitro inhibitory MIC₅₀ and MIC₉₀ ofthe Pithecellobium clypearia Benth 10% ethanol extract and theantibiotics to the MDRPAs MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA800-1600  800 800 CAZ 2-512 32 256 CFP 8-512 64 512 AMK 1-256 1 32 IMP4-64  32 64 LVX 0.5-128  4 32

TABLE P16 Bactericidal MBC₅₀ and MBC₉₀ of the Pithecellobium clypeariaBenth 10% ethanol extract to the MDRPAs MBC (μg/ml) Drug Range MBC₅₀MBC₉₀ EA 1600-3200 1600 1600

TABLE P17 FIC values of the combined drug sensitive test of thePithecellobium clypearia Benth 10% ethanol extract and the fiveantibiotics Strain FIC No. EA + CAZ EA + CFP EA + AMK EA + IMP EA + LVXP1 0.75 0.5 0.5625 0.75 0.625 P2 0.5 1 0.3125 0.28125 0.507813 P3 0.750.375 0.75 0.28125 0.503906 P4 0.5 1 1.5 1 1 P5 0.75 1 1.03125 0.50.53125 P6 0.75 0.625 0.75 0.5625 0.3125 P7 0.75 0.515625 0.5625 0.56251.000977 P8 0.375 0.15625 0.75 0.28125 0.28125 P9 1 1 0.5625 1 1 P100.75 0.75 0.5 0.5 0.75 P11 1 0.75 0.75 0.75 1 P12 0.53125 0.253906 0.50.5625 1 P13 0.5 0.375 0.28125 0.5 1 P14 1 0.53125 0.53125 0.625 0.5625P15 1 0.375 0.53125 0.375 1 P16 0.5 0.375 0.257813 0.375 0.375 P17 0.50.53125 0.5625 0.625 1 P18 1 1 0.5 0.375 1.5 P19 1 0.507813 0.5625 0.3750.75 P20 0.5 0.500977 50.5 1 0.75

TABLE 18 Distribution statistical results of the FIC values of thecombined drug sensitive test of the Pithecellobium clypearia Benth 10%ethanol extract and the five antibiotics EA + EA + EA + EA + EA + FICRange CAZ CFP AMK IMP LVX FIC ≤ 0.5 35% 35% 30% 50% 15% 0.5 < FIC ≤ 165% 65% 55% 50% 75% 1 < FIC ≤ 2 — — 15% — 10% FIC > 2 — — — — —

TABLE P19 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the CAZ and MIC after combined use EA EA CAZ CAZStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 200 32 16 P2 800 200 64 16 P3800 200 4 2 P4 800 200 256 64 P5 800 200 64 32 P6 800 200 512 256 P7 800200 64 32 P8 1600 200 256 64 P9 800 400 8 4 P10 800 200 4 2 P11 800 4002 1 P12 800 400 64 2 P13 800 200 16 4 P14 800 400 16 8 P15 800 400 256128 P16 1600 400 32 8 P17 800 200 32 8 P18 800 400 64 32 P19 800 400 4 2P20 800 200 256 64

TABLE P20 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the CFP and MIC after combined use EA EA CFP CFPStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 200 128 32 P2 800 400 256 128P3 800 200 16 2 P4 800 400 8 4 P5 800 400 512 256 P6 1600 200 512 256 P7800 400 512 8 P8 1600 200 16 0.5 P9 800 400 64 32 P10 800 400 8 2 P11800 200 8 4 P12 800 200 512 2 P13 800 200 256 32 P14 800 400 8 0.25 P15800 200 64 8 P16 1600 200 1024 256 P17 800 400 16 0.5 P18 800 400 256128 P19 800 400 64 0.5 P20 800 400 1024 1

TABLE P21 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the AMK and MIC after combined use EA EA AMK AMKStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 400 1 0.0625 P2 800 200 10.0625 P3 800 200 4 2 P4 800 800 1 0.5 P5 800 800 2 0.0625 P6 1600 800256 64 P7 800 400 1 0.0625 P8 1600 400 1 0.5 P9 800 400 1 0.0625 P10 800200 4 1 P11 800 400 1 0.25 P12 800 200 32 8 P13 800 200 2 0.0625 P14 800400 2 0.0625 P15 800 400 2 0.0625 P16 1600 400 256 2 P17 800 400 10.0625 P18 800 200 16 4 P19 800 400 1 0.0625 P20 800 40000 2 1

TABLE P22 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the IMP and MIC after combined use EA EA IMP IMPStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 200 32 16 P2 800 200 64 2 P3800 200 64 2 P4 800 400 32 16 P5 800 200 64 16 P6 1600 800 32 2 P7 800400 32 2 P8 1600 400 64 2 P9 800 400 32 16 P10 800 200 64 16 P11 800 2008 4 P12 800 400 32 2 P13 800 200 8 2 P14 800 400 32 4 P15 800 200 32 4P16 1600 400 16 2 P17 800 400 16 2 P18 800 200 32 4 P19 800 200 64 8 P20800 400 4 2

TABLE P23 Sensibilization effect of the Pithecellobium clypearia Benth10% ethanol extract to the LVX and MIC after combined use EA EA LVX LVXStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 400 32 4 P2 800 400 4 0.03125P3 800 400 8 0.03125 P4 800 400 8 4 P5 800 400 1 0.03125 P6 1600 400 0.50.03125 P7 800 800 32 0.03125 P8 1600 400 1 0.03125 P9 800 400 4 2 P10800 400 128 32 P11 800 400 2 1 P12 800 400 1 0.5 P13 800 400 2 1 P14 800400 32 2 P15 800 400 2 1 P16 1600 400 32 4 P17 800 400 4 2 P18 800 400 44 P19 800 400 16 4 P20 800 400 4 1

TABLE P24 MIC₅₀ and MIC₉₀ of the five antibiotics after combined useAntibiotic (μg/ml) Combined drug MIC₅₀ after combined use MIC₉₀ aftercombined use EA + CAZ 16 64 EA + CFP 4 256 EA + AMK 0.0625 4 EA + IMP 216 EA + LVX 1 4

With the single use of the Pithecellobium clypearia Benth 10% ethanolextract to the MDRPA, the MIC₅₀ is 800 μg/ml, the MIC₉₀ is 1600 μg/ml,the MBC₅₀ is 1600 μg/ml, and the MBC₉₀ is 1600 μg/ml.

For the 20 MDRPAs, it is indicated by FIC≤2 with the combined use of thePithecellobium clypearia Benth 10% ethanol extract and the CAZ that thetwo drugs have no antagonistic effect, wherein 35% with FIC≤0.5 have thesynergistic effect. For the 20 MDRPAs, when the concentration of thePithecellobium clypearia Benth 10% ethanol extract is smaller than orequal to the single-use MIC, the MIC₅₀ of the CAZ is reduced fromsingle-use 32 μg/ml to 16 μg/ml and is reduced by 50%; and the MIC₉₀ isreduced from 256 μg/ml to 64 μg/ml and is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 10% ethanol extract and the CFP to the 20 MDRPAs thatthe two drugs have no antagonistic effect, wherein 35% with FIC≤0.5 havethe synergistic effect. For the 20 MDRPAs, when the concentration of thePithecellobium clypearia Benth 10% ethanol extract is smaller than orequal to the single-use MIC, the MIC₅₀ of the CFP is reduced fromsingle-use 64 μg/ml to 4 μg/ml and is reduced by 93.75%; and the MIC₉₀is reduced from 512 μg/ml to 256 μg/ml and is reduced by 50%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 10% ethanol extract and the AMK that the two drugs haveno antagonistic effect, wherein 30% with FIC≤0.5 have the synergisticeffect. For the 20 MDRPAs, when the concentration of the Pithecellobiumclypearia Benth 10% ethanol extract is smaller than or equal to thesingle-use MIC, the MIC₅₀ of the AMK is reduced from single-use 1 μg/mlto 0.0625 μg/ml and is reduced by 93.75%; and the MIC₉₀ is reduced from32 μg/ml to 4 μg/ml and is reduced by 87.5%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 10% ethanol extract and the IMP that the two drugs haveno antagonistic effect, wherein 50% with FIC≤0.5 have the synergisticeffect. For the 20 MDRPAs, when the concentration of the Pithecellobiumclypearia Benth 10% ethanol extract is smaller than or equal to thesingle-use MIC, the MIC₅₀ of the IMP is reduced from single-use 32 μg/mlto 2 μg/ml and is reduced by 93.75%; and the MIC₉₀ is reduced from 64μg/ml to 16 μg/ml and is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 10% ethanol extract and the LVX to the 20 MDRPAs thatthe two drugs have no antagonistic effect, wherein 15% with FIC≤0.5 showthat the two drugs have a certain synergistic effect. For the 20 MDRPA,when the concentration of the Pithecellobium clypearia Benth 10% ethanolextract is smaller than or equal to the single-use MIC, the MIC₅₀ of theLVX is reduced from single-use 4 μg/ml to 1 μg/ml and is reduced by 75%;and the MIC₉₀ is reduced from 32 μg/ml to 4 μg/ml and is reduced by87.5%.

2.3. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth 60% ethanol extract and the five antibiotics (the LVX, the IMP,the AMK, the CAZ and the CFP) to the MDRPAs are shown in table P25.

In-vitro bactericidal test results of the Pithecellobium clypearia Benth60% ethanol extract to the MDRPAs are shown in table P26.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth 60% ethanol extract and thefive antibiotics to the MDRPAs is shown in table P27.

The statistic analysis on bactericidal MBC₅₀ and MBC₉₀ of the EA to theMDRPAs is shown in table P28.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth 60% ethanol extract and the five antibiotics anddistribution statistical results of the FIC values are shown in tableP29 and table P30.

The sensibilization effects of the Pithecellobium clypearia Benth 60%ethanol extract to the five antibiotics and the MIC₅₀ and MIC₉₀ aftercombined use are shown in tables P31-P36.

TABLE P25 In-vitro inhibitory test results of the Pithecellobiumclypearia Benth 60% ethanol extract and the five antibiotics to theMDRPAs MIC(μg/ml) Strain No. EA LVX IMP AMK CAZ CFP P1 400 32 32 1 32128 P2 200 4 64 1 64 256 P3 400 8 64 4 4 16 P4 400 8 32 1 256 8 P5 400 164 2 64 512 P6 400 0.5 32 256 512 512 P7 400 32 32 1 64 512 P8 800 1 641 256 16 P9 400 4 32 1 8 64 P10 400 128 64 4 4 8 P11 400 2 8 1 2 8 P12400 1 32 32 64 512 P13 400 2 8 2 16 256 P14 800 32 32 2 16 8 P15 400 232 2 256 64 P16 800 32 16 256 32 >512 P17 400 4 16 1 32 16 P18 400 4 3216 64 256 P19 800 16 64 1 4 64 P20 800 4 4 2 256 >512 ATCC27853 400 1 42 4 8

TABLE P26 In-vitro bactericidal test results of the Pithecellobiumclypearia Benth 60% ethanol extract to the MDRPAs Strain No. MBC (μg/ml)P1 400 P2 400 P3 800 P4 800 P5 800 P6 800 P7 800 P8 800 P9 1600 P10 1600P11 1600 P12 1600 P13 1600 P14 1600 P15 1600 P16 1600 P17 1600 P18 1600P19 1600 P20 1600

TABLE P27 Statistical results on in-vitro inhibitory MIC₅₀ and MIC₉₀ ofthe Pithecellobium clypearia Benth 60% ethanol extract and the fiveantibiotics to the MDRPAs MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 200-800 400 800 CAZ 2-512 32 256 CFP 8-512 64 512 AMK 1-256 1 32 IMP 4-64  32 64LVX 0.5-128  4 32

TABLE P28 Bactericidal MBC₅₀ and MBC₉₀ of the Pithecellobium clypeariaBenth 60% ethanol extract to the MDRPAs MBC (μg/ml) Drug Range MBC₅₀MBC₉₀ EA 400-1600 1600 1600

TABLE P29 FIC values of the combined drug sensitive test of thePithecellobium clypearia Benth 60% ethanol extract and the fiveantibiotics Strain FIC No. EA + CAZ EA + CFP EA + AMK EA + IMP EA + LVXP1 0.375 0.375 1.0625 0.625 0.25 P2 0.625 0.75 0.5625 0.53125 0.5078 P31.125 1.03125 0.5 0.15625 1.0039 P4 0.375 1.0625 1.5 1.0625 1 P5 1.00780.625 1.03125 0.75 1.03125 P6 0.75 1 1.125 1.0625 1.0625 P7 1 0.6251.0625 1.0625 1.0010 P8 0.3125 0.53125 0.5625 0.53125 0.53125 P9 1.06250.625 0.5625 0.75 1 P10 1.125 1.0625 0.375 0.75 0.5 P11 1.25 1.0625 0.751.25 2.0625 P12 0.5078 0.5010 0.375 0.5625 1.5 P13 0.75 0.375 0.531250.5 1.015625 P14 0.375 0.5625 0.53125 0.5 1.03125 P15 0.75 0.375 1.031250.75 2.5 P16 0.375 0.3125 0.5002 0.625 0.53125 P17 0.5 1.03125 1.06251.125 3 P18 0.5 0.625 0.375 1.0625 2.0625 P19 0.625 0.5078 0.56250.53125 0.625 P20 0.3125 0.5005 0.5625 0.625 0.625

TABLE P30 Distribution statistical results of the FIC values of thecombined drug sensitive test of the Pithecellobium clypearia Benth 60%ethanol extract and the five antibiotics EA + EA + EA + EA + EA + FICRange CAZ CFP AMK IMP LVX FIC ≤ 0.5 40% 20% 20% 15% 10% 0.5 < FIC ≤ 135% 55% 45% 55% 35% 1 < FIC ≤ 2 25% 25% 35% 30% 35% FIC > 2 — — — — 20%

TABLE P31 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the CAZ and MIC after combined use EA EA CAZ CAZStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 400 50 32 8 P2 200 100 64 8 P3400 50 4 4 P4 400 50 256 64 P5 400 400 64 0.5 P6 400 100 512 256 P7 400200 64 32 P8 800 50 256 64 P9 400 400 8 0.5 P10 400 400 4 0.5 P11 400400 2 0.5 P12 400 200 64 0.5 P13 400 100 16 8 P14 800 100 16 4 P15 400100 256 128 P16 800 100 32 8 P17 400 100 32 8 P18 400 100 64 16 P19 800400 4 0.5 P20 800 50 256 64

TABLE P32 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the CFP and MIC after combined use EA EA CFP CFPStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 400 50 128 32 P2 200 50 256 128P3 400 400 16 0.5 P4 400 400 8 0.5 P5 400 50 512 256 P6 400 200 512 256P7 400 50 512 256 P8 800 400 16 0.5 P9 400 50 64 32 P10 400 400 8 0.5P11 400 400 8 0.5 P12 400 200 512 0.5 P13 400 100 256 32 P14 800 400 80.5 P15 400 50 64 16 P16 800 50 1024 256 P17 400 400 16 0.5 P18 400 50256 128 P19 800 400 64 0.5 P20 800 400 1024 0.5

TABLE P33 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the AMK and MIC after combined use EA EA AMK AMKStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 400 400 1 0.0625 P2 200 100 10.0625 P3 400 100 4 1 P4 400 400 1 0.5 P5 400 400 2 0.0625 P6 400 400256 32 P7 400 400 1 0.0625 P8 800 50 1 0.5 P9 400 200 1 0.0625 P10 40050 4 1 P11 400 100 1 0.5 P12 400 50 32 8 P13 400 200 2 0.0625 P14 800400 2 0.0625 P15 400 400 2 0.0625 P16 800 400 256 0.0625 P17 400 400 10.0625 P18 400 100 16 2 P19 800 400 1 0.0625 P20 800 50 2 1

TABLE P34 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the IMP and MIC after combined use EA EA IMP IMPStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 400 50 32 16 P2 200 100 64 2 P3400 50 64 2 P4 400 400 32 2 P5 400 200 64 16 P6 400 400 32 2 P7 400 40032 2 P8 800 400 64 2 P9 400 100 32 16 P10 400 200 64 16 P11 400 400 8 2P12 400 200 32 2 P13 400 100 8 2 P14 800 200 32 8 P15 400 200 32 8 P16800 400 16 2 P17 400 400 16 2 P18 400 400 32 2 P19 800 400 64 2 P20 800100 4 2

TABLE P35 Sensibilization effect of the Pithecellobium clypearia Benth60% ethanol extract to the LVX and MIC after combined use EA EA LVX LVXStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 400 50 32 4 P2 200 100 4 0.03125P3 400 400 8 0.03125 P4 400 200 8 4 P5 400 400 1 0.03125 P6 400 400 0.50.03125 P7 400 400 32 0.03125 P8 800 400 1 0.03125 P9 400 200 4 2 P10400 100 128 32 P11 400 25 2 4 P12 400 400 1 0.5 P13 400 400 2 0.03125P14 800 800 32 1 P15 400 800 2 1 P16 800 25 32 16 P17 400 800 4 4 P18400 25 4 8 P19 800 100 16 8 P20 800 100 4 2

TABLE P36 MIC₅₀ and MIC₉₀ of the five antibiotics after combined useAntibiotic (μg/ml) Combined drug MIC₅₀ after combined use MIC₉₀ aftercombined use EA + CAZ 8 64 EA + CFP 4 256 EA + AMK 0.0625 4 EA + IMP 216 EA + LVX 1 8

With the single use of the Pithecellobium clypearia Benth 60% ethanolextract to the MDRPA, the MIC₅₀ is 800 μg/ml, the MIC₉₀ is 1600 μg/ml,the MBC₅₀ is 1600 μg/ml, and the MBC₉₀ is 1600 μg/ml.

For the 20 MDRPAs, it is indicated by FIC≤2 with the combined use of thePithecellobium clypearia Benth 60% ethanol extract and the CAZ that thetwo drugs have no antagonistic effect, wherein 40% with FIC≤0.5 have thesynergistic effect. For the 20 MDRPAs, when the concentration of thePithecellobium clypearia Benth 60% ethanol extract is smaller than orequal to the single-use MIC, the MIC₅₀ of the CAZ is reduced fromsingle-use 32 μg/ml to 8 μg/ml and is reduced by 75%; and the MIC₉₀ isreduced from 256 μg/ml to 64 μg/ml and is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 60% ethanol extract and the CFP to the 20 MDRPAs thatthe two drugs have no antagonistic effect, wherein 20% with FIC≤0.5 havethe synergistic effect. For the 20 MDRPAs, when the concentration of thePithecellobium clypearia Benth 60% ethanol extract is smaller than orequal to the single-use MIC, the MIC₅₀ of the CFP is reduced fromsingle-use 64 μg/ml to 4 μg/ml and is reduced by 93.75%; and the MIC₉₀is reduced from 512 μg/ml to 256 μg/ml and is reduced by 50%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 60% ethanol extract and the AMK that the two drugs haveno antagonistic effect, wherein 20% with FIC≤0.5 have the synergisticeffect. For the 20 MDRPAs, when the concentration of the Pithecellobiumclypearia Benth 60% ethanol extract is smaller than or equal to thesingle-use MIC, the MIC₅₀ of the AMK is reduced from single-use 1 μg/mlto 0.0625 μg/ml and is reduced by 93.75%; and the MIC₉₀ is reduced from32 μg/ml to 2 μg/ml and is reduced by 93.75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 60% ethanol extract and the IMP that the two drugs haveno antagonistic effect, wherein 15% with FIC≤0.5 have the synergisticeffect. For the 20 MDRPAs, when the concentration of the Pithecellobiumclypearia Benth 60% ethanol extract is smaller than or equal to thesingle-use MIC, the MIC₅₀ of the IMP is reduced from single-use 32 μg/mlto 2 μg/ml and is reduced by 93.75%; and the MIC₉₀ is reduced from 64μg/ml to 16 μg/ml and is reduced by 75%.

With the combined use of the Pithecellobium clypearia Benth 60% ethanolextract and the LVX to the 20 MDRPAs, there are four strains with FICgreater than 2 and has the antagonistic effect, wherein 10% with FIC≤0.5show that the two drugs have a certain synergistic effect. For the 20MDRPA, when the concentration of the Pithecellobium clypearia Benth 60%ethanol extract is smaller than or equal to the single-use MIC, theMIC₅₀ of the LVX is reduced from single-use 4 μg/ml to 1 μg/ml and isreduced by 75%; and the MIC₉₀ is reduced from 32 μg/ml to 8 μg/ml and isreduced by 75%.

2.4. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth 95% ethanol extract and the five antibiotics (the LVX, the IMP,the AMK, the CAZ and the CFP) to the MDRPAs are shown in table P37.

In-vitro bactericidal test results of the Pithecellobium clypearia Benth95% ethanol extract to the MDRPAs are shown in table P38.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth 95% ethanol extract and thefive antibiotics to the MDRPAs is shown in table P39.

The statistic analysis on bactericidal MBC₅₀ and MBC₉₀ of thePithecellobium clypearia Benth 95% ethanol extract to the MDRPAs isshown in table P40.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth 95% ethanol extract and the five antibiotics anddistribution statistical results of the FIC values are shown in tableP41 and table P42.

The sensibilization effects of the Pithecellobium clypearia Benth 95%ethanol extract to the five antibiotics and the MIC₅₀ and MIC₉₀ aftercombined use are shown in tables P43-P48.

TABLE P37 In-vitro inhibitory test results of the Pithecellobiumclypearia Benth 95% ethanol extract and the five antibiotics to theMDRPAs MIC(μg/ml) Strain No. EA LVX IMP AMK CAZ CFP P1 800 32 32 1 32128 P2 800 4 64 1 64 256 P3 800 8 64 4 4 16 P4 800 8 32 1 256 8 P5 800 164 2 64 512 P6 800 0.5 32 256 512 512 P7 800 32 32 1 64 512 P8 800 1 641 256 16 P9 800 4 32 1 8 64 P10 800 128 64 4 4 8 P11 800 2 8 1 2 8 P12800 1 32 32 64 512 P13 800 2 8 2 16 256 P14 800 32 32 2 16 8 P15 800 232 2 256 64 P16 800 32 16 256 32 >512 P17 800 4 16 1 32 16 P18 800 4 3216 64 256 P19 800 16 64 1 4 64 P20 800 4 4 2 256 >512 ATCC27853 400 1 42 4 8

TABLE P38 In-vitro bactericidal test results of the Pithecellobiumclypearia Benth 95% ethanol extract to the MDRPAs Strain No. MBC (μg/ml)P1 1600 P2 1600 P3 1600 P4 1600 P5 1600 P6 1600 P7 1600 P8 1600 P9 1600P10 1600 P11 1600 P12 1600 P13 1600 P14 1600 P15 1600 P16 3200 P17 1600P18 1600 P19 1600 P20 1600

TABLE P39 Statistical results on in-vitro inhibitory MIC₅₀ and MIC₉₀ ofthe Pithecellobium clypearia Benth 95% ethanol extract and the fiveantibiotics to the MDRPAs MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 800 800800 CAZ 2-512 32 256 CFP 8-512 64 512 AMK 1-256 1 32 IMP 4-64  32 64 LVX0.5-128  4 32

TABLE P40 Bactericidal MBC₅₀ and MBC₉₀ of the Pithecellobium clypeariaBenth 95% ethanol extract to the MDRPAs MBC (μg/ml) Drug Range MBC₅₀MBC₉₀ EA 1600-3200 1600 1600

TABLE P41 FIC values of the combined drug sensitive test of thePithecellobium clypearia Benth 95% ethanol extract and the fiveantibiotics Strain FIC No. EA + CAZ EA + CFP EA + AMK EA + IMP EA + LVXP1 1 0.5 0.5625 1 0.625 P2 0.75 1 0.3125 0.3125 0.507813 P3 0.75 0.5 10.3125 0.503906 P4 1 1 1.5 0.75 1 P5 1 1 1.03125 0.375 1.03125 P6 1 0.751.125 0.5625 1.0625 P7 0.75 0.515625 0.37 0.5625 1.000977 P8 0.5 0.281250.75 0.5 0.53125 P9 1 1 0.3125 1 1 P10 1 0.375 0.5 0.5 0.75 P11 1 1 10.75 1 P12 0.53125 0.503906 0.5 0.5625 1 P13 0.5 0.375 0.28125 0.75 1P14 1 0.53125 0.53125 0.625 0.3125 P15 1 0.375 0.28125 0.375 1 P16 0.3750.5 0.507813 0.625 0.625 P17 0.375 0.53125 0.5625 0.625 1 P18 1 0.75 0.50.375 1.5 P19 0.75 0.28125 0.5625 0.375 0.5 P20 0.5 0.500977 1 1 0.75

TABLE P42 Distribution statistical results of the FIC values of thecombined drug sensitive test of the Pithecellobium clypearia Benth 95%ethanol extract and the five antibiotics EA + EA + EA + EA + EA + FICStrain No. CAZ CFP AMK IMP LVX FIC ≤ 0.5 25% 40% 40% 40% 10% 0.5 < FIC ≤1 75% 60% 45% 60% 70% 1 < FIC ≤ 2 — — 15% — 20% FIC > 2 — — — — —

TABLE P43 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the CAZ and MIC after combined use EA EA CAZ CAZStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 400 32 16 P2 800 400 64 16 P3800 400 4 1 P4 800 400 256 128 P5 800 400 64 32 P6 800 400 512 256 P7800 200 64 32 P8 800 200 256 64 P9 800 400 8 4 P10 800 400 4 2 P11 800400 2 1 P12 800 400 64 2 P13 800 200 16 4 P14 800 400 16 8 P15 800 400256 128 P16 800 200 32 4 P17 800 200 32 4 P18 800 400 64 32 P19 800 4004 1 P20 800 200 256 64

TABLE P44 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the CFP and MIC after combined use EA EA CFP CFPStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 200 128 32 P2 800 400 256 128P3 800 200 16 4 P4 800 400 8 4 P5 800 400 512 256 P6 800 400 512 128 P7800 400 512 8 P8 800 200 16 0.5 P9 800 400 64 32 P10 800 200 8 1 P11 800400 8 4 P12 800 400 512 2 P13 800 200 256 32 P14 800 400 8 0.25 P15 800200 64 8 P16 800 200 1024 256 P17 800 400 16 0.5 P18 800 200 256 128 P19800 200 64 2 P20 800 400 1024 1

TABLE P45 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the AMK and MIC after combined use EA EA AMK AMKStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 400 1 0.0625 P2 800 200 10.0625 P3 800 400 4 2 P4 800 800 1 0.5 P5 800 800 2 0.0625 P6 800 800256 32 P7 800 200 1 0.12 P8 800 200 1 0.5 P9 800 200 1 0.0625 P10 800200 4 1 P11 800 400 1 0.5 P12 800 200 32 8 P13 800 200 2 0.0625 P14 800400 2 0.0625 P15 800 200 2 0.0625 P16 800 400 256 2 P17 800 400 1 0.0625P18 800 200 16 4 P19 800 400 1 0.0625 P20 800 400 2 1

TABLE P46 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the IMP and MIC after combined use EA EA IMP IMPStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 400 32 16 P2 800 200 64 4 P3800 200 64 4 P4 800 400 32 8 P5 800 200 64 8 P6 800 400 32 2 P7 800 40032 2 P8 800 200 64 16 P9 800 400 32 16 P10 800 200 64 16 P11 800 200 8 4P12 800 400 32 2 P13 800 400 8 2 P14 800 400 32 4 P15 800 200 32 4 P16800 400 16 2 P17 800 400 16 2 P18 800 200 32 4 P19 800 200 64 8 P20 800400 4 2

TABLE P47 Sensibilization effect of the Pithecellobium clypearia Benth95% ethanol extract to the LVX and MIC after combined use EA EA LVX LVXStrain single-use combined-use single-use combined-use No. MIC (μg/ml)MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) P1 800 400 32 4 P2 800 400 4 0.03125P3 800 400 8 0.03125 P4 800 400 8 4 P5 800 800 1 0.03125 P6 800 800 0.50.03125 P7 800 800 32 0.03125 P8 800 400 1 0.03125 P9 800 400 4 2 P10800 400 128 32 P11 800 400 2 1 P12 800 400 1 0.5 P13 800 400 2 1 P14 800200 32 2 P15 800 400 2 1 P16 800 400 32 4 P17 800 400 4 2 P18 800 400 44 P19 800 200 16 4 P20 800 400 4 1

TABLE P48 MIC₅₀ and MIC₉₀ of the five antibiotics after combined useAntibiotic (μg/ml) Combined drug MIC₅₀ after combined use MIC₉₀ aftercombined use EA + CAZ 16 128 EA + CFP 4 128 EA + AMK 0.12 4 EA + IMP 416 EA + LVX 1 4

With the single use of the Pithecellobium clypearia Benth 95% ethanolextract to the MDRPA, the MIC₅₀ is 800 μg/ml, the MIC₉₀ is 800 μg/ml,the MBC₅₀ is 1600 μg/ml, and the MBC₉₀ is 1600 μg/ml.

For the 20 MDRPAs, it is indicated by FIC≤2 with the combined use of thePithecellobium clypearia Benth 95% ethanol extract and the CAZ that thetwo drugs have no antagonistic effect, wherein 25% with FIC≤0.5 have thesynergistic effect.

For the 20 MDRPAs, when the concentration of the Pithecellobiumclypearia Benth 95% ethanol extract is smaller than or equal to thesingle-use MIC, the MIC₅₀ of the CAZ is reduced from single-use 32 μg/mlto 16 μg/ml and is reduced by 50%; and the MIC₉₀ is reduced from 256μg/ml to 128 μg/ml and is reduced by 50%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 95% ethanol extract and the CFP to the 20 MDRPAs thatthe two drugs have no antagonistic effect, wherein 40% with FIC≤0.5 havethe synergistic effect. For the 20 MDRPAs, when the concentration of thePithecellobium clypearia Benth 95% ethanol extract is smaller than orequal to the single-use MIC, the MIC₅₀ of the CFP is reduced fromsingle-use 64 μg/ml to 4 μg/ml and is reduced by 93.75%; and the MIC₉₀is reduced from 512 μg/ml to 128 μg/ml and is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 95% ethanol extract and the AMK that the two drugs haveno antagonistic effect, wherein 40% with FIC≤0.5 have the synergisticeffect. For the 20 MDRPAs, when the concentration of the Pithecellobiumclypearia Benth 95% ethanol extract is smaller than or equal to thesingle-use MIC, the MIC₅₀ of the AMK is reduced from single-use 1 μg/mlto 0.12 μg/ml and is reduced by 87.5%; and the MIC₉₀ is reduced from 32μg/ml to 4 μg/ml and is reduced by 87.5%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 95% ethanol extract and the IMP that the two drugs haveno antagonistic effect, wherein 40% with FIC≤0.5 have the synergisticeffect. For the 20 MDRPAs, when the concentration of the Pithecellobiumclypearia Benth 95% ethanol extract is smaller than or equal to thesingle-use MIC, the MIC₅₀ of the IMP is reduced from single-use 32 μg/mlto 4 μg/ml and is reduced by 75%; and the MIC₉₀ is reduced from 64 μg/mlto 16 μg/ml and is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 95% ethanol extract and the LVX to the 20 MDRPAs thatthe two drugs have no antagonistic effect, wherein 10% with FIC≤0.5 showthat the two drugs have a certain synergistic effect. For the 20 MDRPA,when the concentration of the Pithecellobium clypearia Benth 95% ethanolextract is smaller than or equal to the single-use MIC, the MIC₅₀ of theLVX is reduced from single-use 4 μg/ml to 1 μg/ml and is reduced by 75%;and the MIC₉₀ is reduced from 32 μg/ml to 4 μg/ml and is reduced by87.5%.

III. Inhibitory and bactericidal tests of the ESBL-producing escherichiacoli (hereinafter referred to as an ESBL-producing ECO) resistance ofthe EA and test of the sensibilization effect by respectively using withthe AMK or the SXT

Embodiment 3

1. Test method: the MDRPA (serial No.: E1-E20) strains are tested andare evaluated with reference to the method in the first embodiment.

2. Test Results

2.1. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth water extract and the two antibiotics (the AMK and the SXT) to theESBL-producing ECOs are shown in table E1.

In-vitro bactericidal test results of the Pithecellobium clypearia Benthwater extract to the ESBL-producing ECOs are shown in table E2.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth water extract and the twoantibiotics to the ESBL-producing ECOs is shown in table E3.

The statistic analysis on bactericidal MBC₅₀ and MBC₉₀ of the EA to theESBL-producing ECOs is shown in table E4.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth water extract and the two antibiotics and distributionstatistical results of the FIC values are shown in table E5 and tableE6.

The sensibilization effects of the Pithecellobium clypearia Benth waterextract to the two antibiotics and the MIC₅₀ and MIC₉₀ after combineduse are shown in tables E7-E9.

TABLE E1 MIC (μg/ml) Strain No. EA AMK SXT E1 1600 4 2432/128 E2 1600 162432/128 E3 1600 512 2432/128 E4 1600 4 76/4 E5 1600 16 2432/128 E6 16004 2432/128 E7 1600 32 2432/128 E8 1600 32 2432/128 E9 1600 64 2432/128E10 1600 8 2432/128 E11 1600 32 76/4 E12 1600 32 2432/128 E13 1600 42432/128 E14 1600 8 2432/128 E15 1600 8 2432/128 E16 1600 16 2432/128E17 1600 8 2432/128 E18 1600 128 2432/128 E19 1600 64 152/8  E20 1600 1676/4 ATCC25922 800 4  9.5/0.5

TABLE E2 Strain No. MBC(μg/ml) E1 3200 E2 3200 E3 3200 E4 3200 E5 3200E6 3200 E7 3200 E8 3200 E9 3200 E10 3200 E11 3200 E12 3200 E13 3200 E143200 E15 3200 E16 3200 E17 3200 E18 3200 E19 3200 E20 3200

TABLE E3 MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 1600 1600 1600 AMK 4-512 16 64 SXT 76/4-2432/128 2432/128 2432/128

TABLE E4 MBC (μg/ml) Drug Range MBC₅₀ MBC₉₀ EA 3200 3200 3200

TABLE E5 FIC Strain No. EA + AMK EA + SXT E1 0.75 0.507813 E2 0.3751.003906 E3 0.28125 0.507813 E4 0.75 0.75 E5 0.625 0.507813 E6 10.515625 E7 0.375 0.507813 E8 0.5 0.507813 E9 0.375 0.500061 E10 0.750.507813 E11 0.5 0.375 E12 0.75 0.125485 E13 1.25 0.507813 E14 0.750.507813 E15 0.75 0.500058 E16 0.5 0.125485 E17 0.5 0.507813 E18 0.6250.250977 E19 0.375 0.375 E20 0.5 0.75

TABLE E6 FIC Range EA + AMK EA + SXT FIC ≤ 0.5 50% 25% 0.5 < FIC ≤ 1 45%70% 1 < FIC ≤ 2  5%  5% FIC > 2 — —

TABLE E7 EA EA AMK AMK Strain single-use combined-use single-usecombined-use No. MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) E1 1600400 4 2 E2 1600 200 16 4 E3 1600 400 512 16 E4 1600 400 4 2 E5 1600 20016 8 E6 1600 800 4 2 E7 1600 200 32 8 E8 1600 400 32 8 E9 1600 400 64 8E10 1600 400 8 4 E11 1600 400 32 8 E12 1600 400 32 16 E13 1600 800 4 2E14 1600 400 8 4 E15 1600 400 8 4 E16 1600 400 16 4 E17 1600 400 8 2 E181600 800 128 16 E19 1600 200 64 16 E20 1600 400 16 4

TABLE E8 EA EA SXT SXT Strain single-use combined-use single-usecombined-use No. MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) E1 1600800 2432/128 19/1 E2 1600 1600 2432/128  9.5/0.5 E3 1600 800 2432/12819/1 E4 1600 800 76/4 19/1 E5 1600 800 2432/128 19/1 E6 1600 8002432/128 38/2 E7 1600 800 2432/128 19/1 E8 1600 800 2432/128 19/1 E91600 800 2432/128  0.148438/0.078125 E10 1600 800 2432/128 19/1 E11 1600200 76/4 19/1 E12 1600 200 2432/128  1.1875/0.0625 E13 1600 800 2432/12819/1 E14 1600 800 2432/128 19/1 E15 1600 800 2432/128  0.148438/0.078125E16 1600 200 2432/128  1.1875/0.0625 E17 1600 800 2432/128 19/1 E18 1600400 2432/128  2.375/0.125 E19 1600 400 152/8  19/1 E20 1600 800 76/419/1

TABLE E9 Antibiotic (μg/ml) Combined drug MIC₅₀ after combined use MIC₉₀after combined use EA + AMK 4 16 EA + SXT 19/1 19/1

The test results shows that, with the single use of the Pithecellobiumclypearia Benth water extract to the ESBL-producing ECOs, the MIC₅₀ is1600 μg/ml, the MIC₉₀ is 1600 μg/ml, the MBC₅₀ is 3200 μg/ml, and theMBC₉₀ is 3200 μg/ml.

For the 20 ESBL-producing ECOs, it is indicated by FIC≤2 with thecombined use of the Pithecellobium clypearia Benth water extract and theAMK that the two drugs have no antagonistic effect, wherein 50% withFIC≤0.5 have the synergistic effect. When the Pithecellobium clypeariaBenth water extract is smaller than or equal to ½ MIC, the MIC₅₀ of theAMK is reduced from single-use 16 μg/ml to 4 μg/ml and is reduced by75%; and the MIC₉₀ is reduced from 64 μg/ml to 16 μg/ml and is reducedby 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth water extract and the SXT to the 20 ESBL-producing ECOsthat the two drugs have no antagonistic effect, wherein 25% with FIC≤0.5have the synergistic effect. When the Pithecellobium clypearia Benthwater extract is smaller than or equal to the single-use MIC, the MIC₅₀and the MIC₉₀ of the SXT are respectively reduced from single-use2432/128 μg/ml to 19/1 μg/ml, and are reduced by 99.3%.

2.2. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth 10% ethanol extract and the two antibiotics (the AMK and the SXT)to the ESBL-producing ECOs are shown in table E10.

In-vitro bactericidal test results of the Pithecellobium clypearia Benth10% ethanol extract to the ESBL-producing ECOs are shown in table E11.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth 10% ethanol extract and thetwo antibiotics to the ESBL-producing ECOs is shown in table E12.

The statistic analysis on bactericidal MBC₅₀ and MBC₉₀ of thePithecellobium clypearia Benth 10% ethanol extract to the ESBL-producingECOs is shown in table E13.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth 10% ethanol extract and the two antibiotics anddistribution statistical results of the FIC values are shown in tableE14 and table E15.

The sensibilization effects of the Pithecellobium clypearia Benth 10%ethanol extract to the two antibiotics and the MIC₅₀ and MIC₉₀ aftercombined use are shown in tables E16-E18.

TABLE E10 MIC (μg/ml) Strain No. EA AMK SXT E1 1600 4 2432/128 E2 160016 2432/128 E3 1600 512 2432/128 E4 1600 4 76/4 E5 1600 16 2432/128 E61600 4 2432/128 E7 1600 32 2432/128 E8 1600 32 2432/128 E9 1600 642432/128 E10 1600 8 2432/128 E11 1600 32 76/4 E12 1600 32 2432/128 E131600 4 2432/128 E14 1600 8 2432/128 E15 1600 8 2432/128 E16 1600 162432/128 E17 1600 8 2432/128 E18 1600 128 2432/128 E19 1600 64 152/8 E20 1600 16 76/4 ATCC25922 800 4  9.5/0.5

TABLE E11 Strain No. MBC(μg/ml) E1 3200 E2 3200 E3 3200 E4 3200 E5 3200E6 3200 E7 3200 E8 3200 E9 3200 E10 3200 E11 3200 E12 3200 E13 3200 E143200 E15 3200 E16 3200 E17 3200 E18 3200 E19 3200 E20 3200

TABLE E12 MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 1600 1600 1600 AMK4-512  16 64 SXT 76/4-2432/128 2432/128 2432/128

TABLE E13 MBC (μg/ml) Drug Range MBC₅₀ MBC₉₀ EA 3200 3200 3200

TABLE E14 FIC Strain No. EA + AMK EA + SXT E1 1 0.507813 E2 0.750.507813 E3 0.265625 0.507813 E4 0.5 0.75 E5 0.5 0.507813 E6 1 0.507813E7 0.5 0.507813 E8 0.75 0.507813 E9 0.5 0.500061 E10 0.75 0.507813 E110.5 0.5 E12 0.75 0.250975 E13 1 0.507813 E14 1 0.507813 E15 0.750.500058 E16 0.5 0.125485 E17 0.75 0.507813 E18 0.5 1.000977 E19 0.3750.375 E20 0.5 0.75

TABLE E15 FIC Range EA + AMK EA + SXT FIC ≤ 0.5 50% 20% 0.5 < FIC ≤ 150% 75% 1 < FIC ≤ 2 —  5% FIC > 2 — —

TABLE E16 EA EA AMK AMK Strain single-use combined-use single-usecombined-use No. MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) E1 1600800 4 2 E2 1600 800 16 4 E3 1600 400 512 8 E4 1600 400 4 1 E5 1600 40016 4 E6 1600 800 4 2 E7 1600 400 32 8 E8 1600 800 32 8 E9 1600 400 64 16E10 1600 400 8 4 E11 1600 400 32 8 E12 1600 400 32 16 E13 1600 800 4 2E14 1600 800 8 4 E15 1600 400 8 4 E16 1600 400 16 4 E17 1600 800 8 2 E181600 400 128 32 E19 1600 400 64 8 E20 1600 400 16 4

TABLE E17 EA EA SXT SXT Strain single-use combined-use single-usecombined-use No. MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) E1 1600800 2432/128 19/1 E2 1600 800 2432/128 19/1 E3 1600 800 2432/128 19/1 E41600 800 76/4 19/1 E5 1600 800 2432/128 19/1 E6 1600 800 2432/128 19/1E7 1600 800 2432/128 19/1 E8 1600 800 2432/128 19/1 E9 1600 800 2432/128 0.148438/0.078125 E10 1600 800 2432/128 19/1 E11 1600 400 76/4 19/1 E121600 400 2432/128  2.375/0.125 E13 1600 800 2432/128 19/1 E14 1600 8002432/128 19/1 E15 1600 800 2432/128  0.148438/0.078125 E16 1600 2002432/128  1.1875/0.0625 E17 1600 800 2432/128 19/1 E18 1600 16002432/128  2.375/0.125 E19 1600 400 152/8  19/1 E20 1600 800 76/4 19/1

TABLE E18 Antibiotic (μg/ml) Combined drug MIC₅₀ after combined useMIC₉₀ after combined use EA + AMK 4 16 EA + SXT 19/1 19/1

The test results shows that, with the single use of the Pithecellobiumclypearia Benth 10% ethanol extract to the ESBL-producing ECOs, theMIC₅₀ is 1600 μg/ml, the MIC₉₀ is 1600 μg/ml, the MBC₅₀ is 3200 μg/ml,and the MBC₉₀ is 3200 μg/ml.

For the 20 ESBL-producing ECOs, it is indicated by FIC≤2 with thecombined use of the Pithecellobium clypearia Benth 10% ethanol extractand the AMK that the two drugs have no antagonistic effect, wherein 50%with FIC≤0.5 have the synergistic effect. When the Pithecellobiumclypearia Benth 10% ethanol extract is smaller than or equal to ½ MIC,the MIC₅₀ of the AMK is reduced from single-use 16 μg/ml to 4 μg/ml andis reduced by 75%; and the MIC₉₀ is reduced from 64 μg/ml to 16 μg/mland is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 10% ethanol extract and the SXT to the 20 ESBL-producingECOs that the two drugs have no antagonistic effect, wherein 20% withFIC≤0.5 have the synergistic effect. When the Pithecellobium clypeariaBenth 10% ethanol extract is smaller than or equal to the single-useMIC, the MIC₅₀ and the MIC₉₀ of the SXT are respectively reduced fromsingle-use 2432/128 μg/ml to 19/1 μg/ml, and are reduced by 99.3%.

2.3. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth 60% ethanol extract and the two antibiotics (the AMK and the SXT)to the ESBL-producing ECOs are shown in table E19.

In-vitro bactericidal test results of the Pithecellobium clypearia Benth60% ethanol extract to the ESBL-producing ECOs are shown in table E20.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth 60% ethanol extract and thetwo antibiotics to the ESBL-producing ECOs is shown in table E21.

The statistic analysis on bactericidal MBC₅₀ and MBC₉₀ of thePithecellobium clypearia Benth 60% ethanol extract to the ESBL-producingECOs is shown in table E22.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth 60% ethanol extract and the two antibiotics anddistribution statistical results of the FIC values are shown in tableE23 and table E24.

The sensibilization effects of the Pithecellobium clypearia Benth 60%ethanol extract to the two antibiotics and the MIC₅₀ and MIC₉₀ aftercombined use are shown in tables E25-E27.

TABLE E19 MIC (μg/ml) Strain No. EA AMK SXT E1 800 4 2432/128 E2 800 162432/128 E3 800 512 2432/128 E4 800 4 76/4 E5 800 16 2432/128 E6 1600 42432/128 E7 800 32 2432/128 E8 800 32 2432/128 E9 800 64 2432/128 E10800 8 2432/128 E11 800 32 76/4 E12 800 32 2432/128 E13 400 4 2432/128E14 800 8 2432/128 E15 800 8 2432/128 E16 800 16 2432/128 E17 800 82432/128 E18 800 128 2432/128 E19 800 64 152/8  E20 800 16 76/4ATCC25922 800 4  9.5/0.5

TABLE E20 Strain No. MBC(μg/ml) E1 1600 E2 1600 E3 1600 E4 1600 E5 1600E6 >1600 E7 1600 E8 1600 E9 1600 E10 1600 E11 1600 E12 1600 E13 >1600E14 1600 E15 1600 E16 1600 E17 1600 E18 1600 E19 1600 E20 1600

TABLE E21 MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 400-1600   800 800 AMK4-512  16 64 SXT 76/4-2432/128 2432/128 2432/128

TABLE E22 MBC (μg/ml) Drug Range MBC₅₀ MBC₉₀ EA ≥1600 1600 1600

TABLE E23 FIC Strain no. EA + AMK EA + SXT E1 0.5625 1.0078 E2 0.251.0039 E3 0.2656 1.0001 E4 0.5625 0.75 E5 0.5625 0.5078 E6 0.375 0.2656E7 0.125 0.5078 E8 0.1875 0.5078 E9 0.3125 1.0001 E10 0.5625 0.5078 E110.1875 0.0703 E12 0.1875 0.0630 E13 1.125 1.0039 E14 0.5625 0.5156 E150.3125 1.0001 E16 0.1875 0.0630 E17 0.3125 0.5078 E18 0.375 0.0635 E190.25 0.625 E20 0.3125 0.375

TABLE E24 FIC Range EA + AMK EA + SXT FIC ≤ 0.5 70% 30% 0.5 < FIC ≤ 125% 40% 1 < FIC ≤ 2  5% 30% FIC > 2 — —

TABLE E25 EA EA AMK AMK Strain single-use combined-use single-usecombined-use No. MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) E1 80050 4 2 E2 800 100 16 2 E3 800 200 512 8 E4 800 50 4 2 E5 800 50 16 8 E61600 400 4 0.5 E7 800 50 32 2 E8 800 50 32 4 E9 800 200 64 4 E10 800 508 4 E11 800 50 32 4 E12 800 50 32 4 E13 400 50 4 4 E14 800 50 8 4 E15800 50 8 2 E16 800 50 16 2 E17 800 50 8 2 E18 800 100 128 32 E19 800 10064 8 E20 800 50 16 4

TABLE E26 EA EA SXT SXT Strain single-use combined-use single-usecombined-use No. MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) E1 800800 2432/128 19/1 E2 800 800 2432/128  9.5/0.5 E3 800 800 2432/128 0.148438/0.078125 E4 800 400 76/4 19/1 E5 800 400 2432/128 19/1 E6 1600400 2432/128 38/2 E7 800 400 2432/128 19/1 E8 800 400 2432/128 19/1 E9800 800 2432/128  0.148438/0.078125 E10 800 400 2432/128 19/1 E11 800 5076/4 19/1 E12 800 50 2432/128  1.1875/0.0625 E13 400 400 2432/128 9.5/0.5 E14 800 400 2432/128 38/2 E15 800 800 2432/128 0.148438/0.078125 E16 800 50 2432/128  1.1875/0.0625 E17 800 4002432/128 19/1 E18 800 50 2432/128  2.375/0.125 E19 800 400 152/8  19/1E20 800 100 76/4 19/1

TABLE E27 Antibiotic (μg/ml) Combined drug MIC₅₀ after combined useMIC₉₀ after combined use EA + AMK 4 8 EA + SXT 19/1 19/1

The test results shows that, with the single use of the Pithecellobiumclypearia Benth 60% ethanol extract to the ESBL-producing ECOs, theMIC₅₀ is 800 μg/ml, the MIC₉₀ is 800 μg/ml, the MBC₅₀ is 1600 μg/ml, andthe MBC₉₀ is 1600 μg/ml.

For the 20 ESBL-producing ECOs, it is indicated by FIC≤2 with thecombined use of the Pithecellobium clypearia Benth 60% ethanol extractand the AMK that the two drugs have no antagonistic effect, wherein 70%with FIC≤0.5 have the synergistic effect. When the Pithecellobiumclypearia Benth 60% ethanol extract is smaller than or equal to ¼ MIC,the MIC₅₀ of the AMK is reduced from single-use 16 μg/ml to 4 μg/ml andis reduced by 75%; and the MIC₉₀ is reduced from 64 μg/ml to 8 μg/ml.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 60% ethanol extract and the SXT to the 20 ESBL-producingECOs that the two drugs have no antagonistic effect, wherein 30% withFIC≤0.5 have the synergistic effect. When the Pithecellobium clypeariaBenth 60% ethanol extract is smaller than or equal to the single-useMIC, the MIC₅₀ and the MIC₉₀ of the SXT are respectively reduced fromsingle-use 2432/128 μg/ml to 19/1 μg/ml, and are reduced by 99.3%.

2.4. In-vitro inhibitory test results of the Pithecellobium clypeariaBenth 95% ethanol extract and the two antibiotics (the AMK and the SXT)to the ESBL-producing ECOs are shown in table E28.

In-vitro bactericidal test results of the Pithecellobium clypearia Benth95% ethanol extract to the ESBL-producing ECOs are shown in table E29.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀ andMIC₉₀ of the Pithecellobium clypearia Benth 95% ethanol extract and thetwo antibiotics to the ESBL-producing ECOs is shown in table E30.

The statistic analysis on bactericidal MBC₅₀ and MBC₉₀ of thePithecellobium clypearia Benth 95% ethanol extract to the ESBL-producingECOs is shown in table E31.

FIC values of a combined drug sensitive test of the Pithecellobiumclypearia Benth 95% ethanol extract and the two antibiotics anddistribution statistical results of the FIC values are shown in tableE32 and table E33.

The sensibilization effects of the Pithecellobium clypearia Benth 95%ethanol extract to the two antibiotics and the MIC₅₀ and MIC₉₀ aftercombined use are shown in tables E34-E36.

TABLE E28 MIC (μg/ml) Strain No. EA AMK SXT E1 1600 4 2432/128 E2 160016 2432/128 E3 1600 512 2432/128 E4 1600 4 76/4 E5 1600 16 2432/128 E61600 4 2432/128 E7 1600 32 2432/128 E8 1600 32 2432/128 E9 1600 642432/128 E10 1600 8 2432/128 E11 1600 32 76/4 E12 1600 32 2432/128 E131600 4 2432/128 E14 1600 8 2432/128 E15 1600 8 2432/128 E16 1600 162432/128 E17 1600 8 2432/128 E18 1600 128 2432/128 E19 1600 64 152/8 E20 1600 16 76/4 ATCC25922 800 4  9.5/0.5

TABLE E29 Strain No. MBC(μg/ml) E1 3200 E2 3200 E3 3200 E4 3200 E5 3200E6 3200 E7 3200 E8 3200 E9 3200 E10 3200 E11 3200 E12 3200 E13 3200 E143200 E15 3200 E16 3200 E17 3200 E18 3200 E19 3200 E20 3200

TABLE E30 MIC (μg/ml) Drug Range MIC₅₀ MIC₉₀ EA 1600 1600 1600 AMK4-512  16 64 SXT 76/4-2432/128 2432/128 2432/128

TABLE E31 MBC (μg/ml) Drug Range MBC₅₀ MBC₉₀ EA 3200 3200 3200

TABLE E32 FIC Strain No. EA + AMK EA + SXT E1 1 0.507813 E2 0.5 0.507813E3 0.53125 0.507813 E4 0.5 0.75 E5 0.5 0.507813 E6 0.75 0.507813 E7 0.750.503906 E8 0.75 0.507813 E9 0.75 0.503906 E10 0.75 0.507813 E11 0.750.75 E12 0.5 1.000975 E13 0.75 0.507813 E14 0.75 0.507813 E15 0.750.500058 E16 0.5 0.132813 E17 0.75 0.507813 E18 0.5 1.000977 E19 0.3750.625 E20 0.5 0.75

TABLE E33 FIC Range EA + AMK EA + SXT FIC ≤ 0.5 40%  5% 0.5 < FIC ≤ 160% 85% 1 < FIC ≤ 2 — 10% FIC > 2 — —

TABLE E34 EA EA AMK AMK Strain single-use combined-use single-usecombined-use No. MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) E1 1600800 4 2 E2 1600 400 16 4 E3 1600 800 512 16 E4 1600 400 4 1 E5 1600 40016 4 E6 1600 800 4 1 E7 1600 800 32 8 E8 1600 800 32 8 E9 1600 800 64 16E10 1600 400 8 4 E11 1600 800 32 8 E12 1600 400 32 8 E13 1600 400 4 2E14 1600 800 8 2 E15 1600 400 8 4 E16 1600 400 16 4 E17 1600 800 8 2 E181600 400 128 32 E19 1600 400 64 8 E20 1600 400 16 4

TABLE E35 EA EA SXT SXT Strain single-use combined-use single-usecombined-use No. MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) MIC (μg/ml) E1 1600800 2432/128 19/1 E2 1600 800 2432/128 19/1 E3 1600 800 2432/128 19/1 E41600 800 76/4 19/1 E5 1600 800 2432/128 19/1 E6 1600 800 2432/128 19/1E7 1600 800 2432/128  9.5/0.5 E8 1600 800 2432/128 19/1 E9 1600 8002432/128  9.5/0.5 E10 1600 800 2432/128 19/1 E11 1600 800 76/4 19/1 E121600 1600 2432/128  2.375/0.125 E13 1600 800 2432/128 19/1 E14 1600 8002432/128 19/1 E15 1600 800 2432/128  0.148438/0.078125 E16 1600 2002432/128 19/1 E17 1600 800 2432/128 19/1 E18 1600 1600 2432/128 2.375/0.125 E19 1600 800 152/8  19/1 E20 1600 800 76/4 19/1

TABLE E36 Antibiotic (μg/ml) Combined drug MIC₅₀ after combined useMIC₉₀ after combined use EA + AMK 4 16 EA + SXT 19/1 19/1

The test results shows that, with the single use of the Pithecellobiumclypearia Benth 95% ethanol extract to the ESBL-producing ECOs, theMIC₅₀ is 1600 μg/ml, the MIC₉₀ is 1600 μg/ml, the MBC₅₀ is 3200 μg/ml,and the MBC₉₀ is 3200 μg/ml.

For the 20 ESBL-producing ECOs, it is indicated by FIC≤2 with thecombined use of the Pithecellobium clypearia Benth 95% ethanol extractand the AMK that the two drugs have no antagonistic effect, wherein 50%with FIC≤0.5 have the synergistic effect. When the Pithecellobiumclypearia Benth 95% ethanol extract is smaller than or equal to ½ MIC,the MIC₅₀ of the AMK is reduced from single-use 16 μg/ml to 4 μg/ml andis reduced by 75%; and the MIC₉₀ is reduced from 64 μg/ml to 16 μg/mland is reduced by 75%.

It is indicated by FIC≤2 with the combined use of the Pithecellobiumclypearia Benth 95% ethanol extract and the SXT to the 20 ESBL-producingECOs that the two drugs have no antagonistic effect, wherein 20% withFIC≤0.5 have the synergistic effect. When the Pithecellobium clypeariaBenth 95% ethanol extract is smaller than or equal to the single-useMIC, the MIC₅₀ and the MIC₉₀ of the SXT are respectively reduced fromsingle-use 2432/128 μg/ml to 19/1 μg/ml, and are reduced by 99.3%.

IV. Inhibitory and bactericidal tests of ESBL-producing klebsiellapneumoniae (hereinafter referred to as an ESBL-producing KPN) resistanceof the EA

Embodiment 4

1. Test method: the ESBL-producing KPN (serial No.: K1-K20) strains aretested and are evaluated with reference to the inhibitory andbactericidal test method in the first embodiment.

2. Test Results

In-vitro inhibitory and bactericidal test results of the Pithecellobiumclypearia Benth water extract to the ESBL-producing KPNs are shown intable K1.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀,MIC₉₀, MBC₅₀ and MBC₉₀ of the Pithecellobium clypearia Benth waterextract to the ESBL-producing KPNs is shown in table K2 and table K3.

In-vitro inhibitory and bactericidal test results of the Pithecellobiumclypearia Benth 10% ethanol extract to the ESBL-producing KPNs are shownin table K4.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀,MIC₉₀, MBC₅₀ and MBC₉₀ of the Pithecellobium clypearia Benth 10% ethanolextract to the ESBL-producing KPNs is shown in table K5 and table K6.

In-vitro inhibitory and bactericidal test results of the Pithecellobiumclypearia Benth 60% ethanol extract to the ESBL-producing KPNs are shownin table K7.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀,MIC₉₀, MBC₅₀ and MBC₉₀ of the Pithecellobium clypearia Benth 60% ethanolextract to the ESBL-producing KPNs is shown in table K8 and table K9.

In-vitro inhibitory and bactericidal test results of the Pithecellobiumclypearia Benth 95% ethanol extract to the ESBL-producing KPNs are shownin table K10.

The statistic analysis on in-vitro inhibitory and bactericidal MIC₅₀,MIC₉₀, MBC₅₀ and MBC₉₀ of the Pithecellobium clypearia Benth 95% ethanolextract to the ESBL-producing KPNs is shown in table K11 and table K12.

TABLE K1 In-vitro inhibitory and bactericidal test results of thePithecellobium clypearia Benth water extract to the ESBL-producing KPNsStrain No. MIC(μg/ml) MBC(μg/ml) K1 1600 >1600 K2 1600 >1600 K31600 >1600 K4 1600 >1600 K5 1600 >1600 K6 1600 >1600 K7 1600 >1600 K81600 >1600 K9 1600 >1600 K10 1600 >1600 K11 1600 >1600 K12 1600 >1600K13 1600 >1600 K14 1600 >1600 K15 1600 >1600 K16 1600 >1600 K171600 >1600 K18 1600 >1600 K19 1600 >1600 K20 1600 >1600

TABLE K2 In-vitro inhibitory MIC₅₀ and MIC₉₀ of the Pithecellobiumclypearia Benth water extract to the ESBL-producing KPNs MIC Range MIC₅₀MIC₉₀ 1600 1600 1600

TABLE K3 In-vitro inhibitory MBC₅₀ and MBC₉₀ of the Pithecellobiumclypearia Benth water extract to the ESBL-producing KPNs MBC Range MBC₅₀MBC₉₀ >1600 >1600 >1600

TABLE K4 In-vitro inhibitory and bactericidal test results of thePithecellobium clypearia Benth 10% ethanol extract to the ESBL-producingKPNs Strain No. MIC(μg/ml) MBC(μg/ml) K1 1600 >1600 K2 800 >1600 K31600 >1600 K4 800 >1600 K5 1600 >1600 K6 1600 >1600 K7 1600 >1600 K81600 >1600 K9 1600 >1600 K10 1600 >1600 K11 1600 >1600 K12 1600 >1600K13 1600 >1600 K14 1600 >1600 K15 800 >1600 K16 800 >1600 K17 1600 >1600K18 1600 >1600 K19 1600 >1600 K20 1600 >1600

TABLE K5 In-vitro inhibitory MIC₅₀ and MIC₉₀ of the Pithecellobiumclypearia Benth 10% ethanol extract to the ESBL-producing KPNs MIC RangeMIC₅₀ MIC₉₀ 800-1600 1600 1600

TABLE K6 In-vitro inhibitory MBC₅₀ and MBC₉₀ of the Pithecellobiumclypearia Benth 10% ethanol extract to the ESBL-producing KPNs MBC RangeMBC₅₀ MBC₉₀ >1600 >1600 >1600

TABLE K7 In-vitro inhibitory and bactericidal test results of thePithecellobium clypearia Benth 60% ethanol extract to the ESBL-producingKPNs Strain No. MIC(μg/ml) MBC(μg/ml) K1 1600 >1600 K2 800 >1600 K3800 >1600 K4 800 >1600 K5 1600 >1600 K6 1600 >1600 K7 400 >1600 K8800 >1600 K9 1600 >1600 K10 1600 >1600 K11 1600 >1600 K12 1600 >1600 K13800 >1600 K14 800 >1600 K15 400 >1600 K16 800 >1600 K17 1600 >1600 K181600 >1600 K19 800 >1600 K20 800 >1600

TABLE K8 In-vitro inhibitory MIC₅₀ and MIC₉₀ of the Pithecellobiumclypearia Benth 60% ethanol extract to the ESBL-producing KPNs MIC RangeMIC₅₀ MIC₉₀ 400-1600 800 1600

TABLE K9 In-vitro inhibitory MBC₅₀ and MBC₉₀ of the Pithecellobiumclypearia Benth 60% ethanol extract to the ESBL-producing KPNs MBC RangeMBC₅₀ MBC₉₀ >1600 >1600 >1600

TABLE K10 In-vitro inhibitory and bactericidal test results of thePithecellobium clypearia Benth 95% ethanol extract to the ESBL-producingKPNs Strain No. MIC(μg/ml) MBC(μg/ml) K1 1600 >1600 K2 1600 >1600 K31600 >1600 K4 1600 >1600 K5 1600 >1600 K6 1600 >1600 K7 1600 >1600 K81600 >1600 K9 1600 >1600 K10 1600 >1600 K11 1600 >1600 K12 1600 >1600K13 800 >1600 K14 800 >1600 K15 1600 >1600 K16 1600 >1600 K17 1600 >1600K18 1600 >1600 K19 1600 >1600 K20 1600 >1600

TABLE K11 In-vitro inhibitory MIC₅₀ and MIC₉₀ of the Pithecellobiumclypearia Benth 95% ethanol extract to the ESBL-producing KPNs MIC RangeMIC₅₀ MIC₉₀ 800-1600 1600 1600

TABLE K12 In-vitro inhibitory MBC₅₀ and MBC₉₀ of the Pithecellobiumclypearia Benth 95% ethanol extract to the ESBL-producing KPNs MBC RangeMBC₅₀ MBC₉₀ >1600 >1600 >1600

With the single use of the Pithecellobium clypearia Benth water extractto the ESBL-producing KPNs, the MIC₅₀ is 1600 μg/ml, the MIC₉₀ is 1600μg/ml, and both the MBC₅₀ and the MBC₉₀ are greater than 1600 μg/ml.

With the single use of the Pithecellobium clypearia Benth 10% ethanolextract to the KPNs, the MIC₅₀ is 1600 μg/ml, the MIC₉₀ is 1600 μg/ml,and both the MBC₅₀ and the MBC₉₀ are greater than 1600 μg/ml.

With the single use of the Pithecellobium clypearia Benth 60% ethanolextract to the ESBL-producing KPNs, the MIC₅₀ is 1600 μg/ml, the MIC₉₀is 1600 μg/ml, and both the MBC₅₀ and the MBC₉₀ are greater than 1600μg/ml.

With the single use of the Pithecellobium clypearia Benth 95% ethanolextract to the ESBL-producing KPNs, the MIC₅₀ is 1600 μg/ml, the MIC₉₀is 1600 μg/ml, and both the MBC₅₀ and the MBC₉₀ are greater than 1600μg/ml.

What is claimed is:
 1. A method of treating a disease caused by aMulti-Drug Resistant Acinetobacter Baumanni (MDRAB) resistant infection,comprising administering an MDRAB resistant drug comprising aPithecellobium Clypearia Benth Extract (EA) or an MDRAB resistantantibiotic sensitizing drug comprising an EA.
 2. The method of claim 1,wherein the EA is a Pithecellobium clypearia Benth water extract or aPithecellobium clypearia Benth ethanol extract.
 3. The method of claim2, wherein the Pithecellobium clypearia Benth water extract or thePithecellobium clypearia Benth ethanol extract is prepared with afollowing method: extracting Pithecellobium clypearia Benth coarsepowder with water or an ethanol aqueous solution having a concentrationof 10%-95% by a volume ratio, and then extracting an obtained extractingsolution with ethyl acetate, in which the obtained extract is a finalproduct.
 4. The method of claim 3, wherein the ethanol aqueous solutionis an ethanol aqueous solution having the concentration of 60% by thevolume ratio.
 5. The method of claim 1, wherein the antibiotic is animipenem (IMP) or a Tetracycline (TE) or a Polymycin B (POLB) or aCeftazidime (CAZ) or a Levofloxacin (LVX).
 6. A method of treating adisease caused by a Multi-Drug Resistant Pseudomonas Aeruginosa (MDRPA)resistant infection, comprising administering an MDRPA resistant drugcomprising a Pithecellobium Clypearia Benth Extract (EA) or an MDRPAresistant antibiotic sensitizing drug comprising an EA.
 7. The method ofclaim 6, wherein the EA is a Pithecellobium clypearia Benth waterextract or a Pithecellobium clypearia Benth ethanol extract.
 8. Themethod of claim 7, wherein the Pithecellobium clypearia Benth waterextract or the Pithecellobium clypearia Benth ethanol extract isprepared with a following method: extracting Pithecellobium clypeariaBenth coarse powder with water or an ethanol aqueous solution having aconcentration of 10%-95% by a volume ratio, and then extracting anobtained extracting solution with ethyl acetate, in which the obtainedextract is a final product.
 9. The method of claim 8, wherein theethanol aqueous solution is an ethanol aqueous solution having theconcentration of 60% by the volume ratio.
 10. The method of claim 6,wherein the antibiotic is a Levofloxacin (LVX) or an imipenem (IMP) oran Amikacin (AMK) or a Ceftazidime (CAZ) or a Cefoperazone (CFP).
 11. Amethod of treating a disease caused by an Extended-SpectrumBeta-Lactamase (ESBL) producing Escherichia Coli (ECO) resistantinfection, comprising administering an ESBL-producing ECO resistant drugcomprising a Pithecellobium Clypearia Benth Extract (EA) or anESBL-producing ECO resistant antibiotic sensitizing drug comprising anEA.
 12. The method of claim 11, wherein the EA is a Pithecellobiumclypearia Benth water extract or a Pithecellobium clypearia Benthethanol extract.
 13. The method of claim 12, wherein the Pithecellobiumclypearia Benth water extract or the Pithecellobium clypearia Benthethanol extract is prepared with a following method: extractingPithecellobium clypearia Benth coarse powder with water or an ethanolaqueous solution having a concentration of 10%-95% by a volume ratio,and then extracting an obtained extracting solution with ethyl acetate,in which the obtained extract is a final product.
 14. The method ofclaim 13, wherein the ethanol aqueous solution is an ethanol aqueoussolution having the concentration of 60% by the volume ratio.
 15. Themethod of claim 11, wherein the antibiotic is an Amikacin (AMK) or aCompound Sulfamethoxazole (SXT).
 16. A method of treating a diseasecaused by an Extended-Spectrum Beta-Lactamase (ESBL) producingKlebsiella Pneumonia (KPN) resistant infection, comprising administeringan ESBL-producing KPN resistant drug comprising a PithecellobiumClypearia Benth Extract (EA).
 17. The method of claim 16, wherein the EAis a Pithecellobium clypearia Benth water extract or a Pithecellobiumclypearia Benth ethanol extract.
 18. The method of claim 17, wherein thePithecellobium clypearia Benth water extract or the Pithecellobiumclypearia Benth ethanol extract is prepared with a following method:extracting Pithecellobium clypearia Benth coarse powder with water or anethanol aqueous solution having a concentration of 10%-95% by a volumeratio, and then extracting an obtained extracting solution with ethylacetate, in which the obtained extract is a final product.
 19. Themethod of claim 18, wherein the ethanol aqueous solution is an ethanolaqueous solution having the concentration of 60% by the volume ratio.